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Summary
 This thesis was written at the Department of Biotechnology of Norwegian University of 
Science and Technology (NTNU) and made as a completion of the three-year PhD program. It 
summarises the studies of the thiol redox active mammalian enzymes operating within 
thioredoxin defence system. Aiming to characterize their structural and functional aspects 
high resolution NMR spectroscopy technique was mainly used along with other 
complementary techniques. This study covers four research projects dedicated to the 
following proteins: methionine sulfoxide reductase B1 (MsrB1), thioredoxin (Trx), 
methionine sulfoxide reductase B (MsrBs), and Grx domain of mouse TGR (Grx).  
 The reduction mechanism of MsrB1, focusing on structural aspects of the 
intermolecular protein complex formation between MsrB1 and its functional partner Trx was 
the subject of the first study. 
 Analysis and systematization of the currently available structural data about the key 
members of the cellular antioxidant defence system, MsrB enzymes, were presented in the 
second study. 
 Thioredoxin glutathione reductase (TGR) is a member of the mammalian thioredoxin 
reductase family that has a monothiol glutaredoxin (Grx) domain attached to the thioredoxin 
reductase module. Grx structure determination and characterization was performed in the 
third project.  
  MsrB1 contains zinc ion coordinated by four cysteines. Recombinantly expressed in 
E.coli cells in cobalt-supplemented medium MsrB1 was demonstrated to uptake cobalt ion. 
Structural studies of cobalt-containing MsrB1 were described in the fourth project. 
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I. Introduction 
I.1. Thioredoxin and Glutaredoxin systems
 
 All aerobic life proceses require oxygen. However, aerobic respiration inevitably 
produces reactive oxygen species (ROS) as byproducts, which may damage many cellular 
components icluding nucleic acids, proteins and lipids. The level of ROS production is 
normally controlled by the highly powerful antioxidant systems of the organism. The 
imbalance of the ROS production and the antioxidant defense, causes oxidative stress, which 
through a series of events, deregulates the cellular functions, leading to a various diseases and 
pathological conditions [1,2,3].  
 To prevent the ROS-induced disorders and maintain the redox control of cellular 
processes the organisms utilize two main enzymatic antioxidant systems, thioredoxin (Trx) 
and glutaredoxin (Grx) systems [4]. The key members of two systems are represented in 
Figure I.1.1. 
 
Figure I.1.1. Scheme depicting the key players in defense against the oxidative stress in Trx and Grx systems. 
 
 The Trx system is composed of thioredoxin reductase (TR), thioredoxin (Trx), and Trx 
peroxidase, while the Grx system constitute glutathione reductase (GR), a Ȗ-Glu-Cys-Gly 
tripeptide (GSH), glutaredoxin (Grx), and glutathione peroxidase (GPx). Trxs and Grxs 
belong to a family of thiol-disulfide oxidoreductases, and characterized by the Trx-like fold 
[5] and a common dithiol-disulfide active site motif Cys-X-X-Cys [5,6]. Trxs catalyze a 
reversible reduction of disulfides utilizing its both cysteines in the active site. The N-terminal 
active site cysteine has a low pKa value at around 7 [7] and acts as nucleophile attacking the 
target disulfide, forming a covalent-fixed intermediate, which is in turn reduced by the C-
terminal resolving cysteine, leading to the reduction of target protein and disulfide formation 
in the active site of Trx. This disulfide is reduced by TR using electrons from NADPH (Figure 
I.1.2). Grxs catalyse reactions via two distinct but functionally connected mechanisms. During 
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the first mechanism, so called ‘dithiol mechanism’, the disulfide, formed between the two 
thiol groups upon reduction of protein disulfide (as in Trx), is reduced by one molecule of 
GSH, forming of a mixed disulfide between N-terminal cysteine of Grx and GSH. The 
obtained mixed intermediate disulfide is further reduced by the second molecule of GSH. For 
reduction of protein mixed disulfides (PSSG) Grx utilizes only the N-terminal cysteine, i.e. 
acting via ‘monothiol mechanism’. Glutathione disulfide (GSSG) molecule, formed in both 
reactions, is further regenerated by GR at the expense of NADPH. 
 
Figure I.1.2. Redox cycles and reaction mechanisms of Trxs (A) and Grxs (B). Upon reduction of protein 
disulfide the N-terminal active site cysteine of Trx forms a covalent-mixed disulfide intermediate (A,1), which 
further reduced by its C-terminal active site thiolate (A,2), forming intramolecular disulfide in Trx. Oxidized Trx 
is reduced by TR using electrons from NADPH (A, 3,4). Grxs reduce protein disulfides in a similar manner to 
Trxs (B, 1). Oxidized Grxs are further reduced by GSH, forming Grx-SG intermediate (B,3). Protein 
deglutathionylation reaction also lead to Grx-SG formation (B,5), which is reduced by the second GSH molecule 
(B,4). Picture adapted from [8]. 
 
 NADPH-dependent glutathione reductase (GR) and thioredoxin reductase (TR) are the 
main antioxidant enzymes providing the transfer of reducing equivalents via reversible thiol 
oxidoreduction to the oxidized protein targets in the corresponding systems. Mammalian TRs 
and GRs are homodimers and possess structural and functional homology, although TRs has 
an additional C-terminal Gly-Cys-SeCys-Gly active site, a feature, which also distinguish 
them from their bacterial counterparts [9,10,11,12,13].  
 
I.2. Selenoproteins
 Selenocysteine is one of the naturally occurring amino acids in proteins. In this 
residue, that is a cysteine analog – sulfur is replaced by selenium. These two elements have a 
similar electronegativity (2,58 for sulfur and 2,55 for selenium [14]), however, Se is a 
stronger nucleophile [15,16,17]. Furthermore, the pKa of selenocysteine is more acidic than 
that of cysteine (pKa (Sec) = 5.2–5.6 while pKa value of Cys is around 8.3) [16,18], which 
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makes Sec deprotonated (anionic form) at physiological pH and more reactive, than cysteine. 
Due to the higher selenium nucleophilicity, selenoproteins are typically more active than their 
cysteine (Cys) analogs [19]. This high catalytic activity has been regarded as a key reason 
why Sec is used in biological systems [20,21,22,23].  
 In general, selenoproteins are represented by a small number of protein families, and 
are found in many of bacterial, archaeal and eukaryal species. In eukaryotes Sec is encoded 
during translation by the UGA codon, normally a translation termination codon. This 
mechanism is complex, and requires the Selenocysteine Insertion Sequence (SECIS) in the 
3’UTR region of mRNA and several protein factors [24,25]. The most abundant 
selenoproteins in mammals are the glutathione peroxidases, thioredoxin reductases, 
methionine sulfoxide reductase B1 (MsrB1), selenoproteins M (SelM) and W (SelW). The 
biological advantage of and evolutionary pressure for a catalytic Sec is a subject of debate 
because of the high cellular ‘costs’ of Sec incorporation [24]. 
 
I.3. Metals in proteins 
 
 Metal ions are essential for living cells and are crucial to the structure and function of 
many proteins [26]. Occurrence of the metal ions as enzymatic cofactors is shown in Figure 
I.3. 
 
Figure I.3.1. Distribution of metals as cofactors. Occurrence of various metal ions as cofactors in enzymes with 
known structure, the bars indicating the number of distinct enzymes (EC number) which depend on the given 
metal ion for catalysis. Figure reproduced from [26]. 
 
 In proteins metals serve different functions, such as [27]: 
1. Structural – bound metal forms a structural motif and/or assists correct protein folding; 
2. Metal storage – uptake, binding and release of metals in soluble form; 
3. Electron transfer – bound metal facilitates uptake, storage and release of electrons; 
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4. Dioxygen binding – bound metal facilitates uptake, storage and release of molecular 
oxygen; 
5. Catalytic - bound metal facilitates binding, activation and turnover. 
  
 In proteins metals are bound either to endogenous ligands (backbone or a side chain 
atoms of the same polypeptide) or exogenous ligands (provided by other molecules bound to 
the polypeptide) [27]. A list of endogenous metal ligands is represented in Table I.3.2.  
 
Table I.3.2. A list of endogenous ligands. Endogenous ligands divided into three groups by which atom is 
donating electrons to the metal ion. In the left column the ligand groups are listed, the examples of the metal 
groups are listed in the right column. X represents any residue, unless specific residues are listed in brackets. 
Figure modified from [27]. 
 Many protein-bound metals are divalent metals. The natural order of stability for 
divalent metals sets out a resulting trend (Ca2+< Mg2+< Mn2+ ޒ Fe2+ ޒ Co2+ ޒ Zn2+ < Ni2+ 
ޒCu2+), often called the Irving-Williams series [28]. The trend follows a decrease in ionic 
radii, which leads to stronger metal-ligand bonds. Zn2+ is larger than Cu2+ and, thus, is an 
exeption. It is assumed that proteins insert metals by sponteneous self-assembly [29]. 
 
I.3.1 Transition metals – coordination geometry and ligand field splitting 
 
 Many of the biological metals are transition metals, which have d-orbital electrons. d-
orbital electrons allow many of these metals to appear in a variety of oxidation states.  Many 
of the transition metals allow d-orbital hybridization in complex with ligands, and, thus, 
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coordination of more ligands and a higher variety of the coordination geometries [29]. 
Common geometries of ligand-metal complexes with coordination nnumber 3, 4, 5 and 6 are 
represented in figures I.3.1. and I.3.2. 
 
Figure I.3.1. Common coordination geometries for coordination numbers 3 and 4. Taken from [29].
 
Figure I.3.2. Common coordination geometries for coordination numbers 5 and 6. Taken from [29].
 For a free transition metal ion the d-orbitals are degenerate (equal energy on each 
level). Upon binding with the ligands the d-orbitals of a metal ion become non-degenerate, 
and the energy gap between the orbitals depends on the geometry of the metal-ligand 
complex. This is reffered to as ligand-field splitting. The number of unpaired electrons 
depends on the geometry and the number of the d-orbital electrons (Figure I.3.3) [29]. 
Unpaired electrons are responsible for paramagnetism, a phenomenon with important 
consequences for various spectroscopic methods.  
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Figure I.3.3. Ligand–field splitting diagrams, orbital occupancies, and magnetic properties for d8 Ni (II) 
complexes having octahedral, tetrahedral, and square planar geometries. 
Among all metal ions, Zn2+ is one of the most important trace metal ions in living 
organisms and an essential cofactor in many metabolic enzymes and regulatory proteins [30]. 
Zinc-binding sites in proteins play mainly either catalytic or a structural role and possess 4- or 
6-fold ligand coordination (5-fold coordination is rather rare) [31]. Catalytic Zn2+ binds 
preferentially to water molecules and histidines in catalytic sites of enzymes, such as human 
carbonic anhydrase II [32], carboxypeptidase [33], thermolysin [34] etc. Structural Zn sites 
have four protein ligands (preferentially Cys) and no bound water molecule. Aspartate 
transcarbomylase [35], cytochrome c oxidase [36], horse alcohol dehydrogenase [37], many 
protein kinases [38], tRNA synthases [39], ‘zinc finger’ proteins [40] are some examples of 
enzymes with structural zinc sites. Because of its d10 close-shell electronic configuration, zinc 
is regarded as spectroscopically ‘silent’ metal ion. To spectroscopically characterize proteins’ 
zinc-sites the substitution with several paramagnetic metal ions (Co2+, Ni2+, Mn2+, Cu2+), 
preferentially with Co2+, is often used. Generally, the substitution of Zn2+  by Co2+ in the 
proteins is performed by either displacement of the original metal ion (preparation of the 
apoprotein) followed by addition of Co2+, or by biosynthetic incorporation, which involves 
growing the host organism in a Co2+- supplemented and Zn2+ - deficient medium [41]. The 
latter method is sometimes considered as in vivo substitution of Co2+ for Zn2+ 
[39,42,43,44,45]. Co2+ is a paramagnetic metal ion and has d7 electronic configuration 
(incomplete outer shell), which allows the d-d transitions that absorb within UV-visible 
region. Coordination chemistry and ionic radii similarity makes cobalt an excellent structural 
and functional model for zinc [46]. The ability of Co2+ ion to substitute Zn2+ in proteins was 
reported elsewhere and has been used to study active sites of some naturally occurring zinc 
enzymes [47,48,49]. For many systems with a catalytic zinc-site, Co-substituted enzymes 
exhibited similar or higher catalytic activity [29]. 
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II. Redox proteins in Thioredoxin system 
II.1. Methionine sulfoxide reductase B1 (MsrB1) 
 Although all amino acids are susceptible to oxidation, only two sulfur-containing 
amino acids, cysteine and methionine, could be reversibly oxidised [50]. Cysteines are 
implicated in catalytic cycle of many enzymes, they can contribute to the protein structure 
stabilization via disulfide bond formation or metal ion coordination, and participate in redox 
signaling processes [51]. Methionines, representing one of the major targets of ROS, by its 
reversible oxidation reduce the intracellular level of ROS, restore the enzymatic function of 
oxidized protein and inhibit or induce certain cellular events in the organism. Oxidation of 
methionine results in formation of two enantiomers, S-MetO and R-MetO. Thioredoxin 
system catalyzes the reduction of free and protein–bound MetO via thiol-based 
oxidoreductases methionine sulfoxide reductases (Msrs). Msrs constitute two distinct family 
of enzymes, MsrA and MsrB, each specific for reduction of S-MetO and R-MetO isomers, 
respectively (Figure II.1.1).  
Figure II.1.1. The mechanism of methionine oxidation/reduction. Step I: reversible oxidation of methione gives 
two enantiomers: S- and R-methionine sulfoxide. Step II: irreversible oxidation of methionine sulfoxide to 
methionine sulfone. Picture taken from [52]. 
 
 Mammalians contain three different subclasses of MsrB: MsrB1, MsrB2 and MsrB3. 
While mammalian MsrB1 contains selenocysteine (Sec) in the active site and resolving Cys, 
MsrB2 and MsrB3 contain only a catalytic cysteine residue [53,54]. All of them contain zinc 
ion, coordinated by four cysteines.  
 Among all members of MsrB family selenoprotein MsrB1 is the most active in the 
reduction of MetO. The three-dimensional structure of mammalian MsrB1, containing 
Cys95Sec, has recently been determined by high resolution NMR spectroscopy [55] and is 
represented on Figure II.1.2. It consists of two antiparallel ȕ-sheets. Both N-terminal and C-
terminal regions are flexible. The first ȕ-sheet is three stranded, forming the back side of the 
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structure, whereas the second sheet has five strands forming the front side. The active site is 
situated in the second ȕ-sheet. The four cysteines Cys23, Cys26, Cys71, and Cys74, situated 
outside the protein active site, coordinate zinc ion, stabilizing the structure of MsrB1. 
 
   
Figure II.1.2. Structure of MsrB1 (pdb code 2kv1) [55]. 
 
II.1.1 MsrB1-Thioredoxin interaction 
 The mechanism of a catalytic MetO reduction by Msrs employs a sulfenic acid 
chemistry and S-S/Se-S formation [56,57,58,59,60]. First, a catalytic Sec95 attacks a sufoxide 
moiety of MetO, resulting in formation of selenenic acid intermediate and concomitant release 
of methionine. Second, a resolving Cys4, situated on the mobile N-terminal region, flips in 
towards the catalytic Sec95 and attacks the selenenic acid intermediate forming a 
selenylsulfide bond Cys4-Sec95. Hydrophobic interactions between aromatic residues in the 
N-terminal region and the active site play an important role during the catalysis, assisting the 
movement of the N-terminal region upon formation of the intramolecular disulfide [55,61]. 
The intramolecular disulfide bond in MsrB1 is further reduced by thioredoxin (Trx) [62,63]. 
The proposed thioredoxin-dependent catalytic cycle mechanism for MsrB1 is illistrated on 
Figure II.1.1.1.   
 
Figure II.1.1.1. The biochemical cycle of selenoprotein MsrB1. Picture taken from [52]. 
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 During the intermediate step of the thioredoxin-catalyzed reaction the formation of the 
intermolecular protein complex between thioredoxin and its substrate takes place. Some 
studies suggested that specific structural recognitions exist between them [64,65]. Elucidation 
of the structural aspects of the MsrB1-Trx complex formation would provide a better 
understanding of the full catalytic mechanism. 
II.2. Mammalian thioredoxin glutathione reductase (TGR) 
 Mammalian TRs belong to a family of pyridine nucleotide disulfide oxidoreductases, 
and are represented by three different subclasses: TR1 (cytosolic TR), TR3 (mitochondrial 
TR) and TGR (thioredoxin glutathione reductase). TR1 and TR3 were shown to be essential 
for mouse embryogenesis, and ubiquitously expressed in various tissues and cell types 
[66,67]. TGR is expressed predominantly in testes in cytosol of spermatids at the time of 
mitochondrial sheath formation [68]. Among TRs TGR is unusual because it combines the 
elements of both Trx and Grx systems: TGR has an N-terminal Grx domain, containing a 
monothiol CPHS catalytic motif, naturally fused to a canonical TR module, sequentially 
related to TR1 (Figure II.2.1) [69,70,71,72]. TGR exhibits broad substrate specificity: it can 
reduce various elements of both thioredoxin and glutaredoxin systems. In fact, it was 
demonstrated that TGR can catalyze reactions associated with Grx (deglutathionylation), GR 
(NADPH-dependent reduction of GSSG) and TR (NADPH-dependent reduction of Trx) 
activities [71]. 
 
Figure II.2.1. Schematic representation of the domain organization of mammalian TRs. Picture adapted from 
[73]. All three proteins contain active center disulfides (CxxxC motifs), FAD- and NADPH- binding domains, a 
C-terminal extension of GCUG-tetrapeptide, dimer interface domain and other features of the pyridine 
nucleotide disulfide oxidoreductase family. In addition, TGR contains N-terminal Grx domain. 
 
 Based on the available structures of pyridine nucleotide disulfide oxidoreductases, 
molecular modeling of TGR homodimer was performed (Figure II.2.2) by Sun et al. [71]. In 
the obtained model, Cys-Sec motif of one subunit transfers electrons from the thiol-disulfide 
center (TR module) to Grx domain of the second subunit. The proposed reaction mechanism 
suggested the following electron flow from NADPH through several redox centers within 
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TGR: NADPH ĺ FAD ĺ thiol-disulfide center ĺ the C-terminal Sec-containing 
tetrapeptide ĺ the active site Cys residue within the Grx domain ĺ downstream substrate 
[71]. 
 
Figure II.2.2. Molecular modeling and reaction mechanism of TGR. Panel A) Molecular model of TGR. The TR 
domain of subunit A is shown in green and of subunit B in red. The Grx domain of subunit A is shown in cyan 
and of subunit B in purple. Active centers are circled. Two FAD molecules are shown in blue, and Cys48, 
Cys175, Cys180, Cys613, and Sec614 in both subunits are shown in yellow. Panel B) Molecular model of the 
enzyme active center. FAD molecule is shown in blue.  Cys48, Cys175, Cys180 of subunit A and Cys613 of 
subunit B are shown in yellow. Sec614 of subunit B in shown in red. Predicted interactions of the 
Cys613/Sec614 dipeptide with the disulfide center Cys175/Cys180 and the active center of the Grx domain 
Cys48 are shown by dashed arrows. In the initial step of catalysis by TGR, NADPH reduces FAD. The predicted 
direction of electron flow in subsequent steps of catalysis (A: FADĺA: 
Cys175/Cys180ĺB:Cys613/Sec614ĺA: Cys48). 
 
 In support to the obtained TGR model, the enzymatic studies of the native purified 
protein demonstrated a key role of C-terminal Sec in TGR function [74]. Further studies 
argued that Grx domain of TGR is responsible for Grx and GR activities of the enzyme, and 
its involvment in formation and isomerization of disulfide bonds in spermatids [75].  
 The first NMR analysis of Grx domain of mouse TGR was performed by Shumilina E. 
[76], and as a result 1H, 13C and 15N NMR assignment was reported. Through this study it was 
found that N-terminal part of Grx, containing 22 amino acids, is unstructured. The overall 
resemblance of 15N-1H HSQC patterns between the full-length Grx and its shortened form 
(lacking N-terminal residues) indicated on their structural similarity. Also, the full-length 
protein had a higher stability than the short Grx, and was also missing the HSQC signals, 
corresponding to residues C105 and D106, D74 and A77 in the corresponding spectra. These 
findings may indicate on slight structural differences between the two proteins due to the 
presence/absence of the N-terminal part. The obtainment of the three-dimensional structure of 
Grx would shed light on this phenomenon and, thus, may provide novel aspects of Grx 
function. 
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III. Spectroscopic methods in structural proteomics 
 All spectroscopic methods are based on exposing a sample to electromagnetic 
irradiation of a given frequency or frequency range, upon which scattering or absorbance of 
this irradiation by the sample leads to a change in the recorded output intensity [5]. Different 
spectroscopic techniques operate over different and limited frequency ranges within this broad 
spectrum Figure III.1
Figure III.1: The electromagnetic radiation spectrum. The different frequency ranges of the 
electromagnetic radiation spectrum with subclassification of frequency range. Molecular, nucleic or 
electronic influence of the different frequency ranges are also indicated. 
 
III.1. Nuclear Magnetic Resonance on Proteins 
 NMR spectroscopy and X-ray crystallography are the only two experimental techniques 
which provide a complete protein structure elucidation. Below, the basic principles of NMR 
spectroscopy and the experiments most relevant to this thesis are described. The following 
paragraph is adapted from several sources ([77,78,79,80], ‘Protein NMR - A Practical Guide’ 
website available at http://www.protein-nmr.org.uk/spectra.html) so the references will not be 
further mentioned.
NMR spectroscopy is based on the observation of the resonance frequency of a spin. 
Spin is an intrinsic property that certain isotopes possess while others do not. The preferable 
nuclei for liquid NMR are the spins with the quantum number of one half. The most 
frequently found atoms in proteins, that possess spin of one half, are hydrogen (1H isotope), 
carbon (13C isotope), nitrogen (15N isotope), and phosphorous (31P isotope). Hydrogens, 
having only one proton in the atom nucleus (referred to as a protons) are the most abundant in 
proteins (natural occurrence 99,98%), whereas 13C and 15N make up only 1.1% and 0.4%, 
respectively, of all naturally occuring carbon and nitrogen atoms.  
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 The spin needs to experience a magnetic field and be excited to be observable. After 
excitation, the spin will precess with a resonance frequency (Figure III.1.1, A), and with the 
passage of time will return to equilibrium. The return of magnetization to equilibrium is called 
relaxation, whith the rate depending on the local mobility of the nuclei. When nuclei with a 
spin I=1/2 are placed in a magnetic field there are two possible spin states, either the spin is 
oriented up or the spin is down (Figure III.1.1, A), i.e. the two energy levels generated – Į and 
ȕ (Figure III.1.1).  
 
Figure III.1.1. A) Spin precessing around the magnetic field direction (upward and downward). The precession 
frequency is the same as the resonance frequency of the nuclei. Mz is the sum magnetization vector. B) Energy 
level diagram for a spin with I= ½ in a magnetic field B0. 
 
These energy states are separated by an amount E' , which is field dependent:   
        02hE BJ S'  , 
where h  is the Planck’s constant, J  the gyromagnetic ratio (‘spin intrinsic property’) and 0B  
is the magnitude of the applyied static magnetic field. At equilibrium the magnetization is 
precessing around the field direction in a non coherent manner, which results in non 
observable magnetization. Magnetization becomes coherent, i.e observable, by tilting it away 
from Z-axis into the XY plane applying radio frequency pulse. 
 
Figure III.1.2. The bulk magnetization after perturbation by a pulse. The net magnetization is symbolised by the 
thick vector and called My. 
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Figure III.1.3. The evolution of the net magnetization and the size of the net magnetization vector in X and Y 
directions as a function of time. The points on the curves of the lower parts of the figure illustrate how the 
digitized net magnetization changes with time. 
  
Figure III.1.3 illustrates what happens when a pulse renders magnetization observable and this 
magnetization starts to evolve. In Figure the evolution of magnetization give a frequency 
oscillation of the NMR signal.  
 The observation frequency may be expressed in terms of the magnetogyric ratio and 
the applied field (Larmor law):  
        02 BJQ S . 
 The resonance frequency of the spin depends on the magnetic field, the nuclei and on 
the chemical surroundings of the nuclei. The latter property of the frequency introduces a 
possibility to observe an individual chemical shift of all protons in a protein molecule. 
 During absorption, the magnetic dipole moment of a nucleus deviates from its 
equilibrium position along the direction of the magnetic field (z-axis) towards the xy-plane 
where it is precessing. This tipping of the magnetic dipole moment is recorded by an 
oscillator coil in the instrument (reciever) producing a Free Induction Decay (FID) curve, 
which after Furie transformation transforms the time domain into the frequency domain, thus, 
acquiring an NMR spectrum. 
III.1.1 Spin-spin interactions through electrons 
 Two nuclei that have spins and are connected by chemical bond will be J coupled. 
Scalar coupling is the isotropic part of the J coupling, while dipolar coupling is the anisotropic 
component of the latter. In practice anisotropy of J coupling is rarely observed, therefore, term 
scalar coupling and J coupling is often used as synonyms. The effect of J coupled nuclei will 
affect the spectrum. This is because the J coupling introduces a local field on the J coupled 
nuclei that either is against or along the local field observed at the nuclei. This field difference 
will in turn lead to a splitting of the peak, which complicates the spectrum. Small J couplings 
may not be observable in spectra of molecules with long correlation times (low mobility) and 
thus with wide peaks. Splitting may thus not be observed in biomolecular spectra. They are 
however used to transfer magnetization between nuclei. 
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III.1.2 Nuclear Overhauser Effect 
 When irradiation with RF of one spin (S) causes the perturbation of other nucleus 
spins close in space nuclei (I) via dipole-dipole interactions, the Nuclear Overhauser Effect 
arises, resulting in signal enhancement of other nuclei. The NOE intensity can be related to 
the distance r between the irradiated and observed spin by an equation: 
6
1 ( )cNOE fr
Wf , 
Where ( )cf W  is a function of correlation time, which accounts for the influence of the 
motional averaging process on the observed NOE. 
 The energy diagram of two-spin coupled system is shown in the following figure 
Figure III.1.2. 
 
Figure III.1.2. The energy and transitions of two – spin system.  
  
  W
1I 
and W
1S 
are single quantum transition probability rates for saturated and observed 
spins, respectively. W
2 
and W
0 
are probability rates for double and zero quantum transitions. 
The W
1I 
and W
1S 
rates are responsible for the spin-lattice relaxation process. After saturation 
of the I spin with RF, a population difference will be created across the energy levels that is 
different from that in the unperturbed state. This creates the Nuclear Overhauser Effect at 
unsaturated spin S. The magnitude of NOE can be calculated according to the following 
formula: 
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IJ  and SJ  are the gyromagnetic ratios for spins I and S respectively. 
 
 As can bee seen in the formulae, the magnitude of NOE and its sign depends strongly 
on W
2 and W0 transitions. To induce the spin transition a molecule should rotate with a 
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frequency similar to the difference between the energy levels. The rotation of the molecule, 
and, thus, the correlation time vary depending on the molecular type and solution. 
 For small molecules NOE is positive, for large molecules (like proteins) NOE is 
negative.
III.1.3 NMR experiments with proteins 
 
 NMR spectroscopy technique is an important technique for structure determination of 
biomolecules. Structure determination is a process where structures are calculated by using 
computer algorithms, starting from the primary sequence of the molecules and a set of 
measured interatomic interactions as well as dihedral angles that are structure determining. 
Prior to determining the NMR constraints, the NMR signals must be assigned (the atom in the 
protein responsible for the signal is determined). In principle, there are two different 
approaches to NMR signal assignment. The first one is applicable to small and medium sized 
molecules where only protons are used to resolve the spectra. When the protein is large and 
the spectral resolution is decreased, the approach is different. Such proteins have larger peak 
widths and extensive signal overlap, which introduces ambiguity in chemical shift assignment 
making it difficult to analyze. The signal overlap is solved by increasing the dimensionality of 
the experiments, i.e. by additional protein labeling, which allows signal separation based on 
heteroatom, and, therefore, simplify protein assignment. Labeling means that specific spin 
half isotopes are brought into the molecules either by synthesizing from labeled amino acids 
or by growing proteins from cells systems capable of living off labeled media. The different 
labeling schemes and the typical NMR choice of NMR techniques are shown in Table 1. 
 
Table 1. Suggested protein labeling as a function of molecular size and suggested NMR 
experiments.
Molecular 
mass, kDa 
Residue 
number 
Labeling NMR techniques for structure determination 
0-6 0-50 none 1H, NOESY, TOCSY 
3-12 30-100 15N HSQC, 3D 15N-NOESY-HSQC, 3D 15N TOCSY-
HSQC 
6-20 60-250 15N, 13C HNCA, HNCO, HNCOCA, HNCACB 
15-25 150-200 15N, 13C TROSY type: HNCA, HNCO, HNCOCA, 
HNCACB 
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15-40 150-350 2H, 15N, 13C TROSY type: HNCA, HNCO, HNCOCA, 
HNCACB 
25> 250> 2H, 15N, 13C TROSY type: HNCA, HNCO, HNCOCA, 
HNCACB 
 
 Homonuclear spectra 
 COSY (Correlation Spectroscopy), TOCSY (Total Correlation Spectroscopy) and 
NOESY (Nuclear Overhauser Enhancement Spectroscopy) 2D proton-proton NMR 
spectroscopic techniques are the most often used in the assignment process and subsequent 
structure calculation of smal and medium sized proteins. Figure III.1.3.1 shows a typical 
NMR pulse sequence used on unlabeled samples. 
 
Figure III.1.3.1. Schema illustrating the two time periods giving in 2D spectrum. t2 is the observed signal, while 
t1 is the incremented indirect dimension. MIX is the sequence used to ensure that the signal is transferred 
between spins. Horizontal black bar is the preparation pulse; the red bar illustrates the signal in different 
evolution dimensions. 
 
 Both COSY and TOCSY experiments use the J2 and J3 couplings to transfer 
magnetization between nuclei, which turns up as a cross-peak in the 2D spectrum between 
nuclei the magnetization comes from to the nuclei the magnetization goes to. The COSY 
technique is only efficient at transferring magnetization from a proton connected to one 
carbon to a proton connected to the neighboring carbon. In TOCSY experiments the 
magnetization may be transferred between a chain of J3 connected protons, which means that 
they are able to connect J couplings within an amino acid, but not between the amino acids in 
a row. In NOESY spectra by through space cross relaxation. NOESY signals depend on atoms 
being close in space, but not nessesarily connected through covalent bonds. The upper 
distance for magnetization transfer in a 2D proton-proton NOESY is typically 5Å. 
 
 Heteronuclear spectra 
  The 15N and 13C labeling increases spectral resolution comparing to the 2D spectra, as 
it introduces the third dimension, allowing to assign the chemical shift values of the labeled 
proteins unambiguously. All experiments on 15N and 13C labeled proteins use HSQC 
(Heteronuclear Single Quantum Coherence) type of magnetization transfer (INEPT). In 
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HSQC experiments the magnetization is transferred via J1 couplings to the wanted hetero 
nuclei, which may be either 15N or 13C and back. Observation is done on protons and the 15N 
or 13C are observed indirectly. All experiments below depend on labeling with both isotopes 
unless otherwise stated. In the accompanying illustrations, atoms that are contribute to the 
respective spectra by cross peaks are colored grey, whereas atoms that are involved in 
transferring signals but are not represented with cross peaks are colored blue.  
15N-1H HSQC (requires 15N-labeling) shows cross peaks for each N-HN pair of a 
protein. The spectrum is mostly represented by cross peaks from backbone N-HN, but also 
from side chains of certain amino acids. Since Pro residues do not have N-HN pairs, they are 
not visible in the spectra (Figure III.1.3.2). 
 
Figure III.1.3.2. 15N-1H HSQC: Schematic representation of amino acids of a protein and the atoms involved in 
the effects recorded in an HSQC-experiment. 
 
 All experiments on 15N and 13C labeled proteins use HSQC type of magnetization 
transfer (INEPT transfer step). 
 
 HNCA (3D) correlates the N-HN pair with CĮi and CĮi-1, thus giving two cross peaks 
in the third dimension for each N-HN pair (Figure III.1.3.3). The cross peak for CĮi is usually 
more intense. 
 
Figure III.1.3.3. HNCA: Schematic representation of amino acids of a protein and the atoms involved in the 
effects recorded in an HNCA-experiment.  
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 CBCANH gives individual cross peaks for CĮi, Cȕi, CĮi-1 and Cȕi-1 for each N-HN 
pair. CBCA(CO)NH gives individual cross peaks only for CĮi-1 and Cȕi-1. Comparison of 
the two spectra makes it possible to distinguish which cross peaks belong to which amino acid 
(Figure III.1.3.4).  
 
Figure III.1.3.4. CBCANH and CBCA(CO)NH. Schematic representation of amino acids of a protein and the 
atoms involved in the effects recorded in CBCANH- and CBCA(CO)NH-experiments (left and right, 
respectively). 
 
 HN(CA)CO gives individual cross peaks for COi and COi-1 for each N- HN pair. 
HNCO gives individual cross peaks only for COi-1. Comparison of the two spectra makes it 
possible to distinguish which cross peaks belong to which amino acid (Figure III.1.3.5). 
 
Figure III.1.3.5. HN(CA)CO and HNCO. Schematic representation of amino acids of a protein and the atoms 
involved in the effects recorded in HN(CA)CO- and HNCO-experiments (left and right, respectively). 
 
 HBHANH gives individual cross peaks for HĮi, Hȕi, HĮi-1 and Hȕi-1 for each N- HN 
pair. HAHB(CO)NH gives individual cross peaks only for HĮi-1 and Hȕi-1. Comparison of 
the two spectra makes it possible to distinguish which cross peaks belong to which amino acid 
(Figure III.1.3.6). 
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Figure III.1.3.6. Schematic representation of amino acids of a protein and the atoms involved in the effects 
recorded in HBHANH- and HAHB(CO)NH-experiments (left and right, respectively).   
 
 HCCH-COSY (requires 13C-labeling) establishes correlations of 1H and 13C 
resonances within H-C-C-H molecular fragments using one bond 1H-13C and 13C-13C j 
couplings (Figure III.1.3.7). 
Figure III.1.3.7. Schematic representation of amino acids of a protein and the atoms involved in the effects 
recorded in a COSY-experiment.  
 HCCH-TOCSY (requires 13C-labeling) correlates and gives cross peaks for all 
carbon atoms of a given amino acid (except CO) and all hydrogen atoms of the same amino 
acid (except HN) (Figure III.1.3.8) 
 
Figure III.1.3.8. Schematic representation of amino acids of a protein and the atoms involved in the effects 
recorded in a TOCSY-experiment.  
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III.1.4 NMR on proteins containing paramagnetic metal ions 
 
 Paramagnetic metal ions (pMe) contain at least one unpaired electron. The unpaired 
electron interacts with the nuclei of the atoms directly linked to the metal ion (contact 
interaction) and atoms within a radius of 10-30 Å (dipolar interaction) depending on the metal 
nature.  Examples of pMes found naturally in proteins are Fe2+, Fe3+, Cu2+, Mn2+, Mn3+, Ni2+ 
and Co2+. Not native to a protein pMes could be also introduced via in vitro 
biochemical/chemical methods or creating recombinant proteins with pMe binding sites. A 
paramagnetic metal ion present in protein influences the magnetic properties of surrounding 
nuclei in both time-dependent and time-averaged manner. Time dependent fluctuations arising 
from the unpaired electrons at the metal center provide relaxation mechanisms, leading to the 
shorter T1 (longitudinal) and T2 (transverse) relaxation times, which in the case of T2 leads to 
signal broadening. Time-average magnetic field significantly affects resonance frequencies of 
nuclei close to the paramagnetic center, which results in shifting of many signals outside the 
diamagnetic region. Figure III.1.4. illistrates an example of a 1D proton NMR spectrum of a 
protein, containing paramagnetic metal ion (MsrB1-Co, manuscript). Thus, the presense of 
pMe in proteins complicates their characterization in comparison with proteins containing 
diamagnetic metals or no metal ions, making, NMR characterization of paramagnetic protein 
a challenging endeavour.   
 
Figure III.1.4. A 1D proton NMR spectrum of MsrB1-Co (the manuscript), showing both high chemical shifts 
and signal broadening. 
 A paramagnetic shift 
 In a protein with pMe, the observed chemical shift for a given nucleus can be 
expressed as  
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obs dia pm    G G G  
where obsG  is the observed chemical shift, diaG  is the diamagnetic, and pm G is the 
paramagnetic contribution to the observed chemical shift, respectively. The paramagnetic 
contribution pm G arises from the hyperfine interaction of unpaired electron(s) with the 
nucleus. The hyperfine interactions comprise two terms. First, the Fermi contact term (Aiso) is 
caused by delocalization of the spin density from the metal orbitals onto the ligands orbitals 
[81]. The chemical shift caused by Fermi contact contribution can be expressed as: 
    3
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,   [82] 
where iiF  and iig  (ii= xx, yy, zz) are the principal components of the paramagnetic 
susceptibility tenzor F and the g -tenzor. E  is the Bohr magneton, jJ  is the gyromagnetic 
ratio of the nucleus j, and jisoA  is the Fermi contact contribution between nucleus j and the 
unpaired electron spin. 
 The second term of hyperfine interaction, which can cause an additional paramagnetic 
shift, is the dipolar part. This shift has an isotropic component, which causes the 
pseudocontact shift pcG  if the magnetic susceptibility tenzor of the metal ion is anisotropic or 
if the metal ion has a spin S > ½ and possesses a significant zero-field splitting. It affects the 
chemical shifts of both ligated and not ligated nuclei. The pcG for the spin S=1/2 could be 
expressed as: 
  2 3 2 31 3cos 1 1.5 (sin cos 2 )12pc ax rhR RNG F - F T IS   '   ' ,
0.5( )ax zz xx yyF F F F'    ,
rh xx yyF F F'   ,
where N is Avogadro’s number, axF' and rhF' are axial and rhombic magnetic 
susceptibilities. R ,  -  and I  are the spherical polar coordinates of the nucleus j realtive to 
the principal axes of the F -tenzor. 
 Both terms, the Fermi contact contribution and dipolar part vary both depend on the 
spin state and magnetic anisotropy of the metal ion. 
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III.1.5 Protein structure determination by NMR 
 The procedure of protein structure determination with NMR spectroscopy icludes 
several steps: 
1. Obtaining the needed NMR spectra on the target protein. 
2. Spectrum assignment, which involves determining the amino acid, its sequence position 
and determining which specific nucleus is responsible for a NMR peak. 
3.  Analysis of the structural data. Dihedral angle determination. 
4. Structure calculation based on the obtained available data. 
 Typically all these steps are intertwined, as different spectra and spectral conditions 
may give different (additional) and complementary information, which may sufficiently help 
to solve the structure. 
 Structure determination of proteins is based on the distance information derived from 
NOE, dihedral angles based on the three-bond scalar coupling between nuclei (J3 couplings), 
and from the angular information obtained with residual dipolar couplings. The NOE is 
caused by cross-relaxation of two spins and depends on the distance between these nuclei to 
the power of six. Thus, the observation of a cross-peak in a NOESY spectrum implies a close 
distance between the two nuclei (within 5Å). NOE distance constraints are the most important 
in structure determination of biological molecules by NMR. 
 For the purposes of current work the NOE constraints have been derrived by 
combining 15N-1H-HSQC with the 3D 15N-NOESY, 13C-1H-HSQC with the 3D 13C-NOESY, 
and aro-13C-1H-HSQC with the 3D aro-13C-NOESY, which were subsequently used in 
structure calculation. In addition to the distance constraints, the procedure of protein structure 
determination was supplemented with the torsion angle constrains for the backbone were 
derived using program TALOS (Tosrion angle Likelyhood Obtained from shift and sequence 
similarity). 
 
 Structure calculation and minimization 
 
 Several computer programs have been developed for structure determination of 
biomolecules, one of the most used programs today is CYANA [83]. The caluculation starts 
from an unstructured linear protein/peptide and use torsion angle dynamics approaches to 
calculate structures that fulfill the constraints. The programs generate a set of random 
mobilities for the different residues used in the structure calculations, and the final output 
structure depends on the input constraints. CYANA uses a simulated annealing procedure 
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where the structures receive a high kinetic energy by being heated up, and, thus, able to 
overcome the energy barriers of the potential hypersurface. The system will gain a global 
minimum (the correct fold) and slowly cool down to a normal temperature. Typically about 
100 structures are calculated and the 20 with the lowest energy structures will then be 
investigated further to check how the structures are compared to the structural constraints 
used for the structure calculation.  
 Structure calculation is often an iterative process where the results from one 
calculation are used to evaluate assignments and reassess the structural constraints. The 
quality of the structure improves while the diversity between the structures should decrease, 
as the work on the structure proceeds. The obtained throguh calculation final 20 structures are 
evaluated using constraint violations, visual inspection, and different software e.g. 
PROCHECK-NMR [84].  
 The structure calculations for NMR structures use a simplified force field, where only 
the most dominant part of the conformational energy is used. This is time saving for the 
structure calculation, however, the resulting structures may be unfavourable in terms of full 
‘physical’ energy function. Thus, the final structures from CYANA are further energy 
minimized with a full force field. In the current work, the energy minimizatioin was 
performed by AMBER program [85]. 
III.2. UV-visible spectroscopy 
  
 A wide range of biomolecules absorb light in the ultraviolet and visible frequency 
range often at a characteristic wavelengths. As UV-visible light of a given intensity passes 
through a sample, a fraction of this light is absorbed by the sample. This fraction is 
proportional to the concentration (c) of the species responsible for absorption, the light path 
length through the sample (l) and the molar extinction coefficient (İ) [86]. This relationship, 
called the Lambert-Beer law, is the basis of UV-vis spectroscopy and is expressed as  
     0log IAbs cl
I
H    
where 0I is the intensity of the irradiating light, I  is the intensity of the light leaving the 
sample. 0log I
I
 is called the absorbance, and is often simplified by the designation Abs (or A). 
The molar extinction coefficient varies with the absorbing species, the wavelength of 
irradiating light and solvent [87].  
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IV. Aims and scope of this study 
 
 The main objective of the study was to establish structural and functional pecularities 
of mammalian thiol redox active proteins of thioredoxin system. High-resolution NMR 
spectroscopy was main experimental technique through this work. Three proteins were in 
scope of this study: methionine sulfoxide reductase B1 (MsrB1), its functional partner 
thioredoxin (Trx), and Grx domain of mouse TGR (Grx). 
 Studies of the first two proteins were aiming to determine the amino acids involved in 
protein complex formation between MsrB1 and Trx. This required an oxidized form of MsrB1 
along with its assignment, and a mutant form of Trx at the place of resolving cysteine 
(Ser35Cys), an important factor, providing generation of a stable intermolecular complex 
required for NMR studies. To determine the Trx amino acids participating in protein complex 
formation with oxidized MsrB1, the availability of the backbone assignment of Ser35Cys Trx 
was crucial. Once the stable protein complex was generated and analysed, further aim was to 
characterize the driving forces of protein complex formation, which required generation of its 
model based on protein-protein docking and molecular dynamics simulation. 
 Along with our research, knowledge available in literature regarding MsrB proteins 
accumulated in recent years required systematization. Aiming to summarize what is known to 
date about MsrBs, a review describing evolution, sequential, structural and coordination 
peculiarities of MsrBs was written. 
 Studies of Grx domain of mouse TGR were aiming to determine its three-dimensional 
structure, as it is a critical step in understanding of enzyme’s function and catalytic 
mechanism. Once the structure of Grx was determined, the secondary goals were to 
characterize the role of certain structural elements in Grx function and in entire TGR enzyme. 
 Recombinant expression of MsrB1 in medium containing Co2+ resulted in biosynthesis 
of paramagnetic cobalt-containing MsrB1. Characterization of the obtained protein, in 
particular, the influence of cobalt coordination on enzyme’s structure and function, required 
its NMR assignment. Upon completion of the assignment, further goal was to derive 
pseudocontat shift values and calculate magnetic susceptibility tenzor, a crucial constraints in 
structure determination of paramagnetic protein.  
 The obtained research results are presented in the following papers.  
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V. Summary of Results and Discussions 
V.1. Structural characterization of the Trx-MsrB1 complex (Paper I) 
V.1.1 NMR spectroscopy studies 
NMR studies of stable interprotein complex MsrB1-Trx required production of 
mutants of both oxidized MsrB1 and reduced Trx in sufficient amounts.  Since expression of 
selenocysteine–containing MsrB1 is impossible in bacterial cells, Sec95 of MsrB1 was 
replaced with Cys. To generate a stable interprotein and catalytically not active complex, 
thioredoxin, containing Ser35Cys mutation was obtained. To monitor amino acids 
participating in interprotein complex formation from both proteins, NMR titration was 
performed. However, prior this investigation, a backbone assignment of reduced mutant Trx, 
and assignment of 15N-1H HSQC spectrum of oxidized MsrB1, were carried out. The resulted 
backbone assignment of mutant Trx was deposited in BMRB under the accession number 
16850. Figure V.1.1.1 illustrates a fragment of 15N-1H HSQC spectra of oxidized and reduced 
MsrB1. 
 
Figure V.1.1.1. Fragment of 15N-1H HSQC spectra of oxidized and reduced MsrB1. Green cross-peaks 
belong to reduced MsrB1; oxidized form of MsrB1 corresponds to red cross-peaks. 
 
15N-labeled oxidized MsrB1 was titrated with unlabeled thioredoxin and subsequent 
15N-1H HSQC spectra were recorded. And vice versa, 15N-enriched reduced Trx was titrated 
with unlabeled oxidized MsrB1, followed by recording the corresponding 15N-1H HSQC 
spectra. The residues, experiencing perturbations, i.e. signal broadening or/and chemical shift 
change were mapped for both oxidized MsrB1 and reduced Trx. Figure V.1.1.2 represents a 
fragment of  15N-1H HSQC experiments performed for Trx. 
  
38
              
 Figure V.1.1.2. 15N labelled TrxC35S titration with non-labelled oxidized MsrB1. Green cross-peaks 
belong to free Trx; red – ratio Trx: MsrB1ox=1:1; magenta – ratio Trx: MsrB1ox=1:3. 
 
The analysis of the NMR titration data is represented on the Figures V.1.1.3 and 
V.1.1.4.  
 
Figure V.1.1.3: (a) Chemical shift difference observed for each residue of MsrB1 upon NMR titration by Trx. 
Lower panel shows in red the residues belonging to the protein active site revealing maximal changes upon 
titration. (b) The 3D structure of oxidized mammalian MsrB1. “Hot points” used for molecular docking are 
evidenced in red. 
Figure V.1.1.4: (a) Chemical shift difference observed for each residue of Trx upon NMRtitration by MsrB1. 
Lower panel shows in red the residues revealing maximal changes upon titration. (b) The 3D structure of 
oxidized mammalian Trx. “Hot points” used for molecular docking are evidenced in red. 
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 Cys4-Phe7, Glu65, and Cys95-Phe97 of MsrB1, which belong to the protein’s active 
site and its neignbouring amino acids, were found to be involved in interaction with Trx. 
Throughout the Trx titration by MsrB1 Asp26-Ser35, Val57-Glu68, and Lys72-Met74 were 
found to participate in protein complex formation with MsrB1ox. As in the case with MsrB1, 
the reported residues of Trx belong to its active site and are situated on the external loops 
close in space. The revealed segments are indicated on the Figures V.1.1.3 and V.1.1.4 with 
red colour.  
 
V.1.2 Biocomputing of Trx-MsrB1 complex
   
 The averaged structures of mutants of oxidized MsrB1 and Trx were generated using 
molecular dynamics simulations (Figures V.1.1.3 (b) and V.1.1.4 (b)). To identify possible 
options of mutual arrangement of MsrB1 and Trx protein-protein docking was performed. As 
criteria, a distance of 10 Å between Cys95-Cys4 disulfide of MsrB1 and SȖ  atom Cys32 of 
thioredoxin was used. Based on the obtained NMR data the ‘hot points of docking’ were 
found, and more than 1000 spatial structure orientations were generated, which were further 
sorted into four groups (Table 2). The representative structure of each group was subjected to 
5 ns molecular dynamics simulations. The analysis of the averaged structures of the 
complexes obtained after 5 ns of MD simulations reveal that only for complex D the distance 
SȖCys32 Trx–SȖCys4 MsrB1 remains the smallest among all possible complexes. Therefore, 
the MD trajectory for this complex was extended to 20ns (Figures V.1.2 (a) and V.1.2 (c)). 
 
Table 2. Structural parameters for MsrB1-Trx complexes (four groups) revealed by protein docking. The 
distances between sulphur atom of Cys32 of Trx and the nearest sulphur atom of MsrB1 disulfide bond as well 
as three pairs of the nearest aminoacids approaching in space for each group (to outline the spatial orientation of 
the proteins within a complex) are presented. 
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Figure V.1.2. The snapshots (A, B, and C) of the protein complex formation along the molecular dynamics 
trajectory. The panels (a), (b), and (c) show zoomed views (interactions interfaces) of the snapshots (A) and (C), 
respectively. 
 
 According to MD calculations, the N-terminal tail of MsrB1 upon oxidation gets 
closer to the ȕ-strand of the protein formed by Arg93-Ile96 (Figures V.1.2 (A) and V.1.2 (a)). 
Further, elongation of the mentioned MsrB1’s ȕ-strand occurs additionally involving residues 
I96-S98 accompanied by formation of three additional hydrogen bonds with residues S5-F7 
(Figures V.1.2 (B) and V.1.2 (b)). This newly constituted strand belongs to the N-terminus of 
MsrB1, which now is stabilized by the intramolecular disulfide bond formed upon oxidation. 
At the final stage of the interaction, Trx adjusts its unstructured loop to the newly formed N-
terminal ȕ-strand of MsrB1, leading to formation of interprotein ȕ-sheet, composed of six ȕ-
strands, where five of them belong to MsrB1 and the sixth to Trx (residues K72-M74) 
(Figures V.1.2 (C) and V.1.2 (c)). Thus, in developing of two new ȕ-strands (one 
intramolecular MsrB1 and one intermolecular), nine aminoacids participate. 
 Upon the formation of the protein intermolecular complex, six new hydrogen bonds 
evolve (three of them are interproteins), thus stabilizing the intermolecular complex. Analysis 
of MD trajectories for MsrB1-Trx complex (prior formation of the intermolecular disulfide 
bond) indicates an existence of two conformations of C4-C95 MsrB1 bond. The following 
energies have been obtained (kcal/mol): 3.1 and 3.2 (vw), í0.5 and í1.7 (to), 2.6 and 1.5 
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(total) for “strained” and “relaxed” S– S bond, respectively. During the MD simulations this 
MsrB1 intramolecular S–S bond prefers its “strained” conformation. This bond thus becomes 
totally destabilized by 2.6 kcal/mol for “strained” or by 1.5 kcal/mol for “relaxed” 
conformation. However, the presence of six hydrogen bonds inside the developed interprotein 
ȕ-sheet obviously overcompensates the straining of Cys4-Cys95 bond in MsrB1, as energy 
profit from one hydrogen bond formation in ȕ-sheet can be estimated by í0.78 kcal/mol. 
Therefore, the formation of the interprotein MsrB1-Trx complex becomes energetically 
preferable. 
V.2. Evolution of Structural and Coordination Features within Methionine 
Sulfoxide Reductase B Family (paper II) 
  
 Different classes of Msrs 
 There are two main classes of Msrs: MsrA – which can reduce protein-bound or free 
S-epimer of methionine sulfoxide [88,89,90,91,92,93,94] and MsrB – which reduce both the 
protein-bound R-epimer of MetO, and, with less efficiency, free R-MetO [54,95,96,97]. Since 
each of the Msr classes has its own, different from each other three-dimensional fold, and 
significantly distinct, well conserved amino acid sequence it is possible to refer to the 
convergent evolution for MetO reduction in living organisms [98,99,100,101]. MsrA protein 
sequences, are characterized by the invariable signature motif “GCFWG/C’’ [50,102,103] and 
MsrB - “RXCXN” (where X indicates any amino acid) or in case of MsrB1 - “RXUXF” 
[53,99,104]. Structures of some archaea, bacterial and eukaryotic MsrB proteins have 
previously been determined using either X-ray or NMR techniques (Figure V.2.1).  
 Both MsrA and MsrB were found in the most genomes [53], however, their 
distribution within the life kingdoms is quite different. Without exception, all studied 
eukaryotes and cyanobacteria contain msrA and msrB genes [101]. In prokaryotes, MsrA and 
MsrB genes can form two separate transcription units [100], with not adjacent loci on the 
chromosome. Alternatively, genes can either be transcriptionally [105] or translationally fused 
and form in the last case  the two-domain protein - MsrAB [106]. In prokaryotes, the Msrs 
distribution is rather variable: in some thermophile or anaerobic archaea no Msrs are present. 
Some organisms possess both Msrs, while others only MsrA but no MsrB. However, there are 
no MsrB-containing organisms which would also not contain MsrA [101]. A possible 
explanation for the different MsrA/MsrB distribution in diverse organisms might be the 
existence of an enzymatic stereospecific preference for S-epimers during Met oxidation in 
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cells, or, alternatively, a more damaging effect of S-MetO for the cell. Otherwise, MsrA 
and/or MsrB might have other unknown biochemical functions along with protein repair, 
which would account for their unequal distribution in genomes [101].  
 The number of msrA and msrB ortholog copies also greatly varies in the different 
organisms. For example, E.coli contains one copy of msrA and msrB, Arabidopsis harbors 
five msrAs and nine msrBs, Rhizobium meliloti has three msrA and three msrB genes, while 
mammals have one msrA and three msrB genes, i.e. MsrB1, MsrB2 and MsrB3 
[53,54,93,107,108,109]. Gene duplication is a frequent event in genome evolution across all 
three domains of life. The organism’s necessity to have alleles expressed under different 
conditions might be a possible explanation of this fact [100,110,111,112].   
 
 MsrB subcellular distribution in eukaryotic cells 
  Although MsrB1 does not have clearly predictable nuclear TS, it is rich in positively 
charged residues, which could serve to transfer the protein into the nucleus. Both MsrB2 and 
MsrB3B form of MsrB3 are targeted to mitochondria. Normally, mitochondrial TS are 
represented by about 20–60 amino acid residues with abundant positive charges and frequent 
hydroxylated residues [113]. Targeting sequences are predicted to form amphipathic Į-helices 
in membranes or in membrane-like environments, whereas in aqueous solution they show 
little structural organization [114,115,116,117,118]. Mouse MsrB2 contains a typical 
mitochondrial signal with the high proportion of arginine residues at the N-terminus 
(MARLLRALRGLPLLQAPGRLARG)  [54]. 
 MsrB3 should be considered separately. In humans and other species (e.g. zebrafish) 
MsrB3 were found to be translated in both ER (MsrB3A) and mitochondrial (MsrB3B) forms 
due to alternative splicing that produces contrasting ER and mitochondrial signals [54]. It 
should be noted, that the mitochondrial location of the human MsrB3B, was not immediately 
clear because it had contrasting N- and C-terminal signals [119]: on the N-terminus – 
mitochondrial and on the C-terminus – KDEL-like ER signal [54]. In contrast, rodents  have 
only one form of MsrB3 found only in the ER [119]. At the same time, mouse MsrB3 has 
both ER and mitochondrial signal peptides at the N-terminus: the mitochondrial signal is 
located between the ER signal and the common MsrB domain. The role of the mouse MsrB3 
mitochondrial signal, which is functional if placed as an N-terminal sequence, remains 
unclear and requires further research [119]. MsrB3A and rodent MsrB3 are targeted to ER 
with C-terminus (KDEL-like) ER retention sequence (KAEL for human and RAEL for mouse 
MsrB) [54,119]. 
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 Mitochondria, the major source of ROS in the cell, have two different MsrBs: MsrB2 
and MsrB3B. MsrB2 is the most active at lower concentrations of Met and inhibited by high 
concentrations of the substrate, whereas MsrB3B is most active at concentrations of 
methionine sulfoxide more than 1mM [54]. In addition, these two MsrBs show differential 
tissue expression [120]. The above argumentation might probably explain the occurrence of 
two MsrBs in mitochondria. 
 
 Selenocysteine in Msrs  
 Selenoproteins are typically more active than their cysteine (Cys) mutants due to the 
higher selenium nucleophilicity [19]. This high catalytic activity has been regarded as a key 
reason why Sec is used in biological systems [20,21,22,23]. However, the nearest protein 
environment of Cys or Sec, as well as the overall structure of the protein can significantly 
influence the redox potential of both residues, and the small changes in the amino acid 
composition in the region close to the active site can lead to comparable catalytic efficiency of 
the sulfur homolog of a selenium-dependent enzyme [121]. Thus, only a higher activity of 
selenoproteins cannot be unique reason to use Sec instead of Cys. Sec utilization by living 
organisms is a compromise: on one hand, Sec utilization provides higher activity, a broader 
range of substrates in microenvironmental conditions (e.g. pH) where an enzyme is active. On 
the other hand, there is a limitation imposed by the electron donors (or acceptors, depending 
on the reaction), dependence on selenium, and the availability and complexity of the Sec 
insertion system [121]. 
 Seleno-containing MsrBs are found in invertebrates and vertebrates, but not in bacteria 
or plants [53,122]. Mammals have one selenoprotein MsrB (MsrB1) and two Cys-containing 
homologs (MsrB2 and MsrB3). MsrB1 contains selenocysteine in the place of the catalytic 
cysteine residue normally present in other MsrBs [53,54]. MsrB1 is the most active in the 
reduction of MetO among all members of the MsrB family. The mechanism of a catalytic 
MetO reduction by Msrs employs a sulfenic acid chemistry and S-S/Se-S formation 
[56,57,58,59,60]. 
 
 MsrB structural description 
 Generally, the structure cores of all catalytic and structurally characterized MsrBs 
have a highly similar ȕ-fold consisting of two ȕ-sheets, one with three strands and another 
with five strands (Figure V.2.1). However, there is a dramatic variability with regards to 
length and secondary structure composition of N- and C-terminal regions of these proteins. 
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This can be clearly observed from superimposition of MsrB structures [123]: while the E-core 
is well conserved, the terminal parts of the proteins show significant differences.  
 
Figure V.2.1. Three-dimensional structures of proteins belonging to MsrB family. 
A – MsrB N. Gonorrhoeae, 3HCH, [99]; B – MsrB  X. campestris, 3HCI, [124]; C – MsrB1 H. sapience, 
3MAO, not pubblished; D – MsrB B. subtilis, 1XM0, not pubblished; E – MsrB2 M. musculus, 2L1U, [125]; F – 
MsrB1 M. musculus, 2KV1,[126]. 
 
 Comparative structural analysis revealed the differences between selenoprotein and 
non-selenoprotein MsrBs, which corresponds to different mechanisms employed by these 
enzymes. The presence of D-helical structures in the N-terminal region of bacterial MsrBs 
suggests that large structural alterations during catalytic act are unlikely in these enzymes due 
to rigidity imposed by D-helices. Instead, the absence of any secondary structure in the N-
terminus of Sec-containing MsrB1 does not impose any rigidity constraints. As a result, the 
catalytic reaction in Sec-containing MsrB1 occurs through the formation of internal selenide-
sulfide bridge between the catalytic Sec and the resolving Cys situated on mobile N-terminus, 
while the reaction between methionine sulfoxide and other MsrBs occurs through formation 
of sulfenic acid intermediate, and any disulfide bridge is formed within this reaction [127]. 
Such peculiarities of catalytic reactions between Sec- and Cys-containing proteins are the 
result of evolutionary changes of catalytic Cys to Sec accompanied by other adaptations such 
as distinct resolving Cys and flexible N-terminus. 
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 Another aspect of structural comparison of MsrBs (Figure V.2.1) is that mammalian 
MsrB2 is more similar to bacterial MsrBs rather than to mammalian MsrB1 as it contains 
three D-helices on the exterior of the protein in the N-terminal region. Indeed, the proposed 
catalytic mechanism for mammalian MsrB2 protein is the same as that proposed for bacterial 
MsrBs [125]. This observation indicates that the functional similarities within MsrB family 
are determined not by the organism, but rather by the nature of the catalytic residue and the 
protein secondary structure.  
 
 Zinc ion in MsrB  
 Sequence analysis of MsrBs homologs shows the existence of proteins with two 
different set of metal binding sites: one with the “classic” four Cys ligands for zinc binding 
and another with different “not classic” amino acids at the correspondent coordinating 
positions [128]. It was suggested the existence of a strictly Zn-dependent family of proteins 
and a family that normally has Zn in metal binding site with four cysteines, but it can be 
expressed also as zinc-independent forms where cysteine ligands are substituted by other 
residues [129]. Thus, for some protein family the same protein may exist either with zinc or 
without. 
 The majority of MsrB proteins, including MsrB1, MsrB2, MsrB3 and the most part of 
bacterial MsrB, have four cysteines that bind Zn ion [103,130]. Some of the bacterial MsrB 
subclasses, however, have only Zn-independent forms (e.g. MsrB domain of MsrAB from 
Neisseriaceae, Bacillus sp. and St. pneumoniae), some have  only Zn-containing forms (MsrB 
from B. pseudomallei, X. campestris) and others -  both forms (MsrB from S. meliloti; V. 
cholera) (unpublished result from [128]). Several structures of MsrB proteins are presently 
reported (Figure V.2.2). Some of them are characterized by the presence of Zn ion, while 
other lacks it. From the structural comparison (Figure V.2.2), it is evident that both Zn-
containing and Zn-independent forms have identical structure of metal binding site among 
themselves and to the corresponding region of no metal homologs. All of them have two 
unstructured loops between four ȕ-sheets. This region seems very well conserved in all the 
reported structures. In the cases where Zn ion is absent, it is possible that some other bonds 
and not the Zn ion preserve the fold of the region. Some Zn-binding site studies were carried 
out by different laboratories [103,130]. In these studies it was shown that in MsrB from 
Drosophila and E.coli mutation of Cys at the positions 23, 26, 71 and 74 (numbering 
corresponds to MsrB1 from Mus musculus) on GSGS, DSSS and DSSA results in Zn losing 
by protein. The reversible mutation of DSSS pattern to CCCC results in a more stable, Zn-
containing protein. It was suggested, that the role of the metal in Zn-containing MsrBs is to 
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stabilize the core structure and thus, to adopt the active site conformation for efficient 
reductase activity. However, as it was stressed, this assumption is in apparent contradiction 
with the fact that the bacterial MsrB, lacking the two CXXC signatures is as active as the Zn-
containing MsrB [130]. It was suggested that a more careful analysis of stabilizing elements 
for MsrBs that do not contain CXXC motif should be performed.   
 
 
Figure V.2.2. Three-dimensional structure of Zn-binding site and thecorresponding regions of MsrBs family. For 
the explanation see text. A - MsrB1, M. musculus,  2KV1, [123]; B - MsrB1, H. sapience, 3MAO, not published; 
C - MsrB2, M. musculus, 2L1U, [125]; D  - MsrB, X. campestris, 3HCI, [124]; E - B. pseudomallei, 
3CEZ/3CXK, not published; a – MsrB, N. meningitidis, 3HCH, [124]; b - MsrB , N. gonorhoeae, 1L1D, [99]; c- 
MsrB, S. pneumoniae 3E0O, [131]; d – MsrB, B.subtilis, 1XM0 not published. Blue color: cysteine and “not 
classic” ligands in metal binding site; magenta:  catalytic cysteine. 
 
 
 
Figure V.2.3. Occurrence of Zn-dependent and Zn-independent forms of representative Zn protein families in 
bacteria. Zn (+), organisms only containing Zn-dependent form; Zn (-), organisms only containing Zn-
independent form; Both, organisms containing both forms. The figure is taken from [128].
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V.3. Structure determination of Grx domain of mouse TGR (paper III) 
 The determination of Grx structure, for which full assignment was already performed 
and deposited (BMRB accession number 17636), required the obtainment of NOE distance 
constraints. For this purpose the C13 and N15-labeled Grx was recombinantly expressed and 
purified, and subsequently the C13-1H-HSQC with 3D C13-NOESY, 15N-1H HSQC with 3D 
15N-NOESY, and aro C13-1H-HSQC with 3D aro-C13-NOESY NMR spectra were aqcuired, 
and analysed. To obtain the latter two spectra, the sample buffer was exchanged to D2O, 
which allowed to monitor signals belonging to aromatic residues buried in protein core. NOE 
cross-peaks of the first 22 amino acid residues of Grx were beyond detection (it was 
previously established that this region is mobile), therefore, the acquired spectra were 
assigned within the range of Ala23 to Asp124, thus, excluding the N-terminal part. The 
closest structural analog, Grx of human TGR (pdb code 3H8Q), was used as a reference. As a 
result, total 894 NOE geometrical constraints were derived, of which 733 were both long- and 
medium-range distance constraints. In addition to distance constraints 182 dihedral angle 
constraints for Grx were obtained from TALOS. Both distance and dihedral angle constraints 
were further imported into CYANA2.1 for structure calculation. The final 20 structures were 
further energy minimized in AMBER 9. The 20 structure conformers of Grx obtained in 
CYANA were deposited in PDB under the code 2lv3. Figure V.3 illustrates the obtained 
superimposition of 20 minimized conformers with the lowest target function and the ribbon 
representation of the minimized conformer closest to the mean structure of Grx with the 
secondary structure elements. 
 
Figure V.3 Solution structure of the reduced Grx domain of mouse TGR. Left: overview of backbone 
superimposition of 20 conformers with the lowest target function. Right: overview of the ribbon representation 
of the minimized conformer closest to the mean structure, the active site cysteine (C48) and C-terminal C105 are 
marked. 
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 Grx domain is a compact Trx-like spherical molecule with a central core of four-
stranded ȕ-sheets flanked on either side by five Į-helices arranged in the order Į1-ȕ1-Į2-ȕ2-Į3-
ȕ3-ȕ4-Į4-Į5 (Figure V.3). The N-terminal region begins with an Į1 (residues Arg 24 - Glu 36), 
followed by ȕ1 consisting of residues Val 40 to Ser 44. The active site Cys 48 - Ser 51 (-
CPHS- motif) is situated on the unstructured loop between ȕ1 and Į2 (residues Arg 53 – Ser 
59). The strand ȕ2 comprises residues Asn 66 to Glu 69; following a loop, Į3 consists of 
residues Gly 76 to Ser 87, followed by ȕ3 (Asn 94 – Val 97) and ȕ4 (Val 100 – Gly 103). The 
C-terminal region includes Į4 (residues Arg 107 – Asn 114) and Į5 (residues Leu 116 – Leu 
120), connected through a hinge section. Strands ȕ1 and ȕ2 are parallel, and strand ȕ3 is 
antiparallel with ȕ1 and ȕ4. Helices Į1 and Į3 pack on one side of the ȕ-sheet, whereas Į2, Į4 
and Į5 are on the other. Packing of the sandwich-like architecture is mainly maintained by 
hydrophobic interactions between the sheet and helices. The determined Grx structure shares 
significant structural similarity with the modelled Grx domain of mouse TGR. 
 
V.3.1 Analysis of the N-terminal part of Grx 
 The N-terminal region was left beyond the structure calculation because of lack of 
corresponding NOE signals. However, bioinformatics studies of this region predicted that it 
features a mitochondrial targeting sequence. Mitochondrial origin of this sequence was further 
supported by our NMR data. Being insoluble in water solutions, mitochondrial signals in 
membraine-like environment are predicted to form amphipathic Į-helixes. To examine the N-
terminal part of Grx, the protein was treated with negatively charged detergent SDS, a 
substance which is widely used in NMR for preparation of membrane-like media. 
Subsequently recorded 15N-1H HSQC spectra clearly demonstrated the appearance of a 
number of new cross-peaks (Figure V.3.1.1), which indicates on formation of protein’s 
secondary structure. Aiming to improve the quality, the temperature for acquiring the spectra 
was slightly increased up to 30°C and 42°C. The number of the new cross-peaks 
corresponded to the expected for the N-terminal part. This observation proves structurization 
of the positively charged N-terminus in negatively charged environment.  
  
49
 
Figure V.3.1.1. A fragment of 15N-1H HSQC spectra of the reduced Grx domain of mouse TGR. Green shows 
Grx HSQC spectrum at 30°C, light blue shows Grx HSQC spectrum in the presence of SDS at 30°C, and black 
corresponds to Grx HSQC spectrum in the presence of SDS at 42°C. 
  
 Interestingly, the full-length protein assignment was lacking several amino acids 
(C105, D106, D74, A77), because of the broadening of corresponding NMR signals. 
However, when the N-terminal part was cut, these signals were assigned. Based on this 
finding it was porposed that the N-terminus could have an impact on these residues through 
electrostatic interactions. Figure V.3.1.2 shows electrostatic potential calculated for the 
obtained structure of Grx. As can be seen, the four missing amino acids (C105, D106, D74, 
A77) are positioned in the negatively charged region, which could be suggested to interact 
with the positively charged N-terminus, and therefore lead to the broadening of NMR signal. 
This hypothesis could explain why these signals were observed in the short form of Grx. 
 
Figure V.3.1.2. Surface charge distribution of the reduced Grx domain of mouse TGR. 
 
Another interesting observation was found during the D2O exchange experiments, 
performed for the full-length Grx and its short form.  During the first 30 minutes in D2O, Grx 
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exchanged ten residues more with respect to sGrx (D33, G37, N38, V40, S59, V63, D71, 
Q72, E85, T108). However, after 3 hours of incubation in D2O, both Grx and sGrx reveal an 
similar pattern of exchanged/not exchanged residues. Altogether these experiments showed 
that although the final rate of water exchange is the same both for Grx and sGrx, the short 
term dynamics of the water exchange is different for Grx and sGrx. The observed differences 
mostly regard residues belonging to the negative patch involved in the suggested interaction 
with the positively charged N-terminus (see above). The fact that these residues exchanged 
within the first 30 min in Grx, while in sGrx they exchanged only 3 hours later indicates that 
the N-terminus in some way promotes faster rates of water diffusion into Grx protein.  
V.3.2 Characterization of GSH binding site 
 Sequence alignment of the domains with other Grx and Grx domains revealed a 
characteristic GSH-binding site, which was further characterized with the help of NMR. In 
particular, the NMR titration experiments were performed, where 15N-labeled Grx was titrated 
with unlabelled both oxidized and reduced glutathione. Residues experiencing chemichal shift 
change and/or signal broadening upon titration with the substrate were detected and analysed. 
As a result, the NMR titration demonstrated that Grx binds oxidized and reduced glutathione 
via the same residues. Fragments of 15N HSQC experiments and the analysed data are 
represented on figure V.3.2. 
 
Figure V.3.2. Fragments of 15N-1H HSQC spectra of 15N-labeled reduced Grx domain of mouse TGR titrated 
with unlabelled GSH and GSSG (panels A and B, respectively). Green corresponds to free Grx and magenta to 
Grx incubated with GSH/GSSG. Only the residues for which alteration of NMR parameters upon titration was 
observed are marked. Panel C: qualitative representation of the data. Solid and dashed horizontal lines below the 
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Grx amino acid sequence highlight the residues interacting with GSH and GSSG, respectively, and, as can be 
seen, significantly overlap. The N-term of Grx is marked in blue.  
 
V.4. Competitive Zinc for Cobalt Substitution in Mammalian MsrB1 
Overexpressed in E.coli: Structural and Functional Insights (Paper IV) 
 
 MsrB1 recombinantly expressed in E.coli cells in M9 media, supplemented with 
cobalt chloride, resulted in light blue colour of the protein. The presence of cobalt ion within 
MsrB1 was proven by its 1D proton NMR spectra, which contained several paramagneticaly 
shifted signals, and UV-visible spectra (Figure V.4A), which exhibited absorption bands at 
345, 635, 665, 695 and 725 nm, characteristic for CysSĺCo2+ LMCT band, and d-d transition 
bands of Co
2+ 
respectivelydiagnostic of tetrahedral coordination geometry. 

Figure V.4A. The electron UV-visible absorption spectra of reduced MsrB1 protein at pH=5.5; black – MsrB1-
Co, grey – MsrB1-Zn.  
 
 The fact that cobalt ion is coordinated to MsrB1 protein indicates that Co
2+
 is present 
in MsrB1 either at the same position as Zn
2+
 ion replacing it, or cobalt binds to another 
protein site, and the resulted MsrB1 protein containes both metals. A pattern of 1H-15N HSQC 
spectrum MsrB1, expressed in zinc-containing medium was different from the one, expressed 
in cobalt supplemented medium. However, 1H-15N HSQC pattern of their equimolar mixture 
was identical to 1H-15N HSQC of MsrB1 expressed in medium containing both zinc and 
cobalt. This observation allowed to conlcude that when both metals are present in the medium 
the expression of two forms MsrB1-Zn and MsrB1-Co takes place. 
 Activity measurements performed for both MsrB1-Zn and MsrB1-Co (reduction of 
MetO) showed similar results (Figure V.4B). 
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
Figure V.4B. Enzyme activity of MsrB1-Co (dashed) and MsrB1-Zn (solid). 
 
 The fact that the two protein forms have similar level of activity may indicate the same 
fold. To structurally characterize MsrB1-Co NMR spectroscopy was further used. 
V.4.1 NMR studies of MsrB1-Co 
To observe all paramagnetically influenced NMR signals of MsrB1-Co protein, 1H 
NMR spectrum was recorded using proton dedicated probe at 600 MHz spectrometer, which 
possesses higher sensitivity and allows to increase the number and intensities of proton 
signals in 1H NMR spectrum. The full 1H NMR spectrum of MsrB1-Co derivative is reported 
in Figure V.3.1.1. As can be observed from the figure, the paramagneticaly shifted signals can 
be found as far as of 350 ppm and they are as broad as 16000 Hz (signal at 347 ppm).  As it is 
known, paramagnetic Co2+ ion has electronic configuration of d7 and can be found in its 
either low (S=1/2) or high spin (S=3/2). The pattern observed in 1H NMR spectrum of 
MsrB1-Co (Figure V.4.1) according to the available literature data [132] indicate that in the 
case of MsrB1-Co high spin cobalt ion is coordinated to the protein. 
 
Figure V.4.1. 1D NMR spectrum of MsrB1-Co, acquired at 600MHz, 298K.  
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V.4.1.1. Heteronuclear NMR assignment of MsrB1-Co 
 
To structurally characterize MsrB1-Co heteronuclear assignment of the protein was 
performed. Of the polypeptide backbone, 64% amino acids were assigned (79 of the total 
124), side chains assignments of MsrB1-Co covered 62 out of 79 residues for which backbone 
assignment were accomplished, which constitute 50% of the entire protein.  
Through the analysis of D2O exchange experiments it was identified 18 residues with 
HN with very slow solvent exchangability rate: Phe 12, Val 20, Tyr 21, Ala 45, Phe 46, Ile 
50, His 51, Val 55, Lys 61, Leu 67, Phe 82, Phe 94, Phe 97, Ser 100, Leu 101, Val 104, Ala 
112 and Leu 117. Lack of exchangability with deuterium is generally an indication that the 
HN are involved in a strong hydrogen bond, typical for residues which are part of a tightly 
packed hydrophobic core of the protein [133]. Consistent with this, all the identified residues 
have hydrophobic side chains. 
In the downfield region of the 1H NMR spectrum there are eight signals which are the 
broadest (in the spectrum) and shifted from 80 to 350 ppm signals signals A-H (Figure V.4.1). 
Since the four cysteines making up the zinc-binding site in the native structure were 
unassigned (S1), it was supposed that the mentioned signals belong to eight ȕ-CH2 protons of 
four cysteines coordinating cobalt ion as they are the closest to paramagnetic center, and 
therefore, should have the maximal both contact and dipolar paramagnetic contribution to 
chemical shifts and relaxation values among all MsrB1-Co protons.  
The undertaken attempts to find pairwise assignment within these eight extremely 
broad signals through 1D NOE spectra did not result in observation of any connecting 
constraints.  However, some NOE’s among the observed paramagnetic signals were observed 
as shown in Figure V.4.1.1. The signals A-H tentatively assigned as ȕ-CH2 protons of four 
coordinating cysteines, while much sharper signals, observed upon saturation of signals C and 
D (Figure V.4.1.1B), tentatively assigned as HĮ proton signals of the same Cys residue to 
which belong the saturated signals. In addition, the fact that upon saturation of signals C and 
D different NOEs are observed indicates that signals C and D belong to different cysteines 
coordinating Co ion.  
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Figure V.4.1.1. A) 1D NOE spectra saturating signals C and D. B) Signals, observed upon saturation of 
C and D signals, and assigned as HĮ protons of the same Cys residue to which belong the saturated signals. 
V.4.1.2. Comparative analysis of MsrB1-Zn and MsrB1-Co 
Comparison of 1H and 15N resonanses of pure zinc– and pure cobalt- MsrB1 
derivatives showed that generally almost all NH and N resonances within the protein changed 
their chemical shifts passing from MsrB1-Zn to MsrB1-Co. This may mean that MsrB1 either 
structurally changes upon Zn for Co substitution or the latter paramagnetic ion strongly 
affects all chemical shifts within MsrB1 protein while the structure of the protein by itself 
remains invariable. Figure V.4.1.2. illustrates the chemical shift differences observed for 
amidic protons as a function of their distance from cobalt ion (supposing that the cobalt ion 
takes the same position as Zn ion in MsrB1 protein). 
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Figure V.4.1.2. A plot of PCS versus the distance from NH group of each MsrB1 residue to zinc ion 
(hypothetically to Co ion). 
 
This behavior is in agreement with the expected pseudocontact paramagnetic contribution to 
the observed chemical shift which is reversed to the distance between the nucleus and 
paramagnetic center in power of three [132].  However, several amino acids (T49, I50, H51, 
D53, S54, V55, F97, S99, S100, and L101) diverge from this rule. These residues constitute 
two unstructured loops residing on the opposite site of the two structural CxxC-motifs, 
demonstrated to be responsible for cobalt coordination. Also, N-terminal residues, which have 
slightly positive PSCs, were found to deviate from the rule. This may indicate that N-terminus 
spends significant time in proximity of the metal binding site. Indeed, the superimposition of 
all the 20 conformers of MsrB1 revealed fixed core and many allowed conformations for N-
and C-termina (Figure V.4.1.3, [126]), including the proximity to the metal binding site. 
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Figure V.4.1.3. The 20 calculated conformers for MsrB1 with lowest target function overlayed. ȕ-strands 
indicated in yellow and loops and flexible chains - in green. 
 
Also, as the catalytic activity assumes the formation of a disulfide bridge between Cys95 and 
Cys4, it is expected that the latter, residing on the N-terminus, would tend towards proximity 
of the catalytic Cys, positioned near the metal binding site.  
 
V.4.1.3. Obtainment of the structure of MsrB1-Co 
 
 For the obtainment of the structure of MsrB1-Co the minimized MsrB1-Zn (2kv1) and 
the experimental pseudo contact shift values were used. The obtained structure of MsrB1-Co 
was found to be eventually very similar to that of MsrB1-Zn. The active site presents little 
reorientation of the side chain of the coordinating cysteins and a movement of about 1 Å for 
the metal ion. Figure V.4.1.3.1 illustrates the superimposition of MsrB1-Zn (grey) and 
MsrB1-Co (cyan) active sites.    
 
 
Figure V.4.1.3.1. Structural comparison of metal-binding site of MsrB1-Zn (2kv1, grey) and MsrB1-Co 
(cyan), obtained with the minimization through AMBER program on the base of the experimental pseudocontact 
shift values. 

The magnetic susceptibility tensor calculated for MsrB1-Co protein (Ȥax=15.19 x10-32 m3 and 
Ȥrh=-0.97 x10-32m3) showed a good agreement between the experimental and calculated 
pceudocontact shift values (Figure V.4.1.3.2), which is an indication of a good quality 
structure of MsrB1-Co. The identified tensor presents a prevalent axial component which is in 
accordance with a disordered tetrahedral high-spin Co2+ coordination reported for other 
systems like Co-rubredoxin and Co-desulforedoxin [134]. 
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Figure V.4.1.3.2. Plot of the observed vs calculated PCSs in the minimized MsrB1-Co structure.  
 
The performed study describes a phenomenon of Co for Zn substitution in mammalian 
protein, MsrB1, under expression in prokaryote cells (E.coli). The uptake of the correct metal 
by the individual polypeptide chains in bacterial cells is achieved by the metal ion 
concentration gradient in the cytosol and periplasm, decreasing and increasing with the 
Irving-Williams series. The zinc sensory protein (which regulates zinc efflux) has dissociation 
constant of magnitude 10-12 M, which means that the zinc concentration above 10-12 M keeps 
the zinc efflux protein active. Conversely, the dissociation constant of the cobalt sensory 
protein is in the magnitude of 10-7 M [135]. Thus, the intracellular concentration of cobalt ion 
is 100,000 times higher than for zinc to begin cobalt efflux, which compensates for the lower 
affinity to ligands. In addition, the ionic radius of zinc in tetrahedral coordination is closer to 
cobalt than to any other metal in the Irving-Williams series (0.60 and 0.58 A respectively) 
[136]. Perhaps that the Co2+ uptake by MsrB1 upon expression in E.coli is due to both 
intracellular conditions created by E.coli and the zinc ionic radii similarity. However, the 
question whether the same phenomenon is relevant for mammalian cells remains and requires 
further studies.
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VI. Further work 
VI.1. Structural analysis of the mammalian TGR function 
The determined structure of Grx allowed characterization of its glutathione binding 
site. It was also found that Grx has the same binding site for both oxidized and reduced 
glutathione. However, structural characterization of the GR activity of TGR, its catalytic 
mechanism and the level of Grx involvement in this process remains to be estimated. The 
knowledge of the structure of the TR module, and, thus, the whole TGR enzyme, along with 
applied biocomputing tools would help to understand the full catalytic mechanism of this 
enzyme.  
VI.2. Characterization of bacterial MsrBs using Cobalt as a probe 
 Since the presense of zinc ion in MsrB proteins was predicted by bioinformatics based 
on the two Zn-binding CXXC motifs, many of the bacterial MsrBs, that contain different 
well-conserved amino acids at the positions of the four cysteines, were reported to not bind 
zinc ion. However, the structures of metal binding site in zinc-containing protein and the 
corresponding region in MsrBs without metal are very similar. The reported MsrB structures 
lacking zinc ion less tightly coordinate it by non-cysteine residues and simply loose zinc ion 
upon purification. We demonstrated that MsrB1 easily substitutes zinc for cobalt upon 
expression in cobalt-supplemented medium; the same method could be applied to study other 
MsrB proteins and, therefore, experimentally confirm their ability to bind zinc by non-
cysteine ligands. 
VI.3. Further characterization of MsrB1-Co 
 Our finding and characterization of MsrB1-Co questions the role of Zn ion in MsrB 
enzymes. MsrB1-Co has shown to reduce methionine sulfoxide at the similar level as the 
native protein. Therefore, it would be interesting to test whether the protein complex 
formation between MsrB1-Co and Trx will take place.   
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Maintenance of the cellular redox balance has vital importance for correcting organism functioning. Methionine sulfoxide
reductases (Msrs) are among the key members of the cellular antioxidant defence system. To work properly, methionine sulfoxide
reductases need to be reduced by their biological partner, thioredoxin (Trx). This process, according to the available kinetic data,
represents the slowest step in the Msrs catalytic cycle. In the present paper, we investigated structural aspects of the intermolecular
complex formation between mammalian MsrB1 and Trx. NMR spectroscopy and biocomputing were the two mostly used through
the research approaches. The formation of NMR detectable MsrB1/Trx complex was monitored and studied in attempt to
understand MsrB1 reduction mechanism. Using NMR data, molecular mechanics, protein docking, and molecular dynamics
simulations, it was found that intermediate MsrB1/Trx complex is stabilized by interprotein β-layer. The complex formation
accompanied by distortion of disulﬁde bond within MsrB1 facilitates the reduction of oxidized MsrB1 as it is evidenced by the
obtained data.
1. Introduction
Oxygen is vital for all aerobic biological processes. However,
about 5% of it is converted into reactive oxygen species
(ROS) [1]. Methionine residues in proteins are susceptible
to oxidation by reactive oxygen and nitrogen species leading
to formation of methionine sulfoxide (MetSO). This modi-
ﬁcation can result in loss of proteins’ function [2]. Organ-
isms developed a complex antioxidant defence system that
includes enzymatic and nonenzymatic antioxidants [3–5].
Methionine sulfoxide reductases (Msrs) are redox repairing
enzymes which reduce MetSO back to methionine (Met). A
number of published reports describe the role of methio-
nine sulfoxide reductases in antioxidant defence and the
regulation of protein function [6–10]. Methionine sulfoxide
reductases reduce both free and protein-bound MetSO, back
to Met in the presence of thioredoxin (Trx). Two distinct
families constitute Msrs: MsrA, which speciﬁcally reduces S-
epimer, and MsrB, which is stereospeciﬁc for R-epimer of
methionine sulfoxide [11–14].
Mammalian MsrB enzymes constitute three diﬀerent
subclasses: MsrB1, MsrB2, and MsrB3 [15–20]. All of them
contain Zn2+ ion, coordinated by two motifs CxxC (two
cysteines separated by two residues), which stabilize their
structure. Whereas mammalian MsrB1 contains a resolving
cysteine (Cys4) and catalytic selenocysteine (Sec95) in its
active site, the other two subclasses, MsrB2 and MsrB3, in
analogy with bacterial MsrBs, contain only catalytic cysteine
[21–24]. NMR solution [25] and X-ray crystal (PDB entry
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3MAO) structures of mammalian MsrB1 have recently been
determined.
Reduction of methionine sulfoxide by selenocysteine
containing MsrB1 is a multistep process [24, 25]. First, a
catalytic Sec95 attacks a sulfoxide moiety of the substrate,
MetSO, resulting in the formation of selenenic acid inter-
mediate and concomitant release of methionine. Second,
a resolving Cys4 attacks the selenenic acid intermediate to
form an intramolecular selenide-sulﬁde bond, and ﬁnally, a
fully reduced enzyme is regenerated by reduction of the latter
bond with thioredoxin, a natural electron donor (Scheme 1).
It has been established that thioredoxin is the natural re-
ducing agent for the members of Msr family, though DTT
can be used as the reductant in vitro [14, 24, 26]. Reduction
of oxidized MsrB2 and MsrB3 as well as of the most bac-
terial MsrBs occurs through a similar mechanism without
formation of the intramolecular disulﬁde bridge. However, it
was reported that bacterial MsrB from Neisseria meningitides
upon oxidation form intramolecular disulﬁde bridge [27].
It was shown that its reduction by Trx is overall rate-limit-
ing step of MsrB cycle and it is described as an apparent
irreversible process.
Thioredoxin is a ubiquitous protein that plays an impor-
tant role in maintaining redox balance in cells [28]. In most
of its reactions, Trx reduces substrate disulﬁde bond. The
proposed mechanism of Trx-catalysed substrate disulﬁde
reduction [29–31] includes nucleophilic attack by thiolate
of Cys32 supported by hydrophobic interactions resulting in
transient mixed disulﬁde formation followed by nucleophilic
attack of the resolving Cys35 generating Trx-S2 and reduced
protein.
Summarising, reduction of MsrBs (mammalian and bac-
terial) disulﬁde bond by Trx, can be described by the fol-
lowing steps. First, thioredoxin and MsrB form an intermo-
lecular complex. In the second step, the just-formed inter-
molecular bond gets resolved by the thioredoxin resolving
cysteine 35, followed by the formation of reduced MsrB
and oxidized Trx. Subsequently, the S–S bridge of oxidized
thioredoxin is further reduced by NADPH and the speciﬁc
FAD-containing enzyme thioredoxin reductase. Some stud-
ies suggest that speciﬁc structural recognitions exist between
oxidized substrate disulﬁde bond and reduced Trx [14, 32].
The knowledge of the structure aspects of the MsrB/Trx
complex formation would help to understand full catalytic
mechanism of methionine sulfoxide reductases.
Here, we have investigated the structural aspects of the
interaction between mammalian oxidized MsrB1 and re-
duced thioredoxin. Mutants of MsrB1 and Trx were pro-
duced in order to get an intermolecular complex suitable
for its investigation using NMR spectroscopy. Firstly, since
Sec-containing MsrB1 is not possible to express in bacterial
cells, Sec95 of MsrB1 was replaced by Cys giving Sec95Cys
mutant (hereafter MsrB1). Further, thioredoxin containing
a Cys35Ser mutation (hereafter Trx) was obtained as this
modiﬁcation removes the second resolving Cys35 leading
to the formation of a detectable intermediate MsrB1-Trx
(Scheme 2). The resultant MsrB1-Trx complex is stable
and could, therefore, be structurally characterized by NMR
spectroscopy and with the aid of computational approach.
2. Materials and Methods
2.1. Microorganisms and Plasmids. The genes of C-terminal
his-tagged mouse MsrB1 (Sec95Cys) and human Trx
(Cys35Ser) mutants, cloned into pET21 expression vectors
were kindly provided by Professor V. Gladyshev’s group.
Escherichia coli strains ER2566 (New England Biolabs) and
BL21 (DE3) (Novagen) cells were respectively transformed
with the constructs using the standard protocol [33]. The
transformed cells were spread on several LB agar plates con-
taining 100 mg/L of ampicillin and were further stored at
4◦C.
2.2. Protein Expression, Puriﬁcation, and Sample Preparation.
E. coli BL21(DE3) cells carrying plasmid pET21-Trx and
E. coli ER2566 cells containing pET21-MsrB1 were grown
in LB-media with 100 mg/L ampicillin. To uniformly label
proteins either with 15N or with 15N-13C, cells were grown in
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M9 minimal media containing 1 g/L 99%-enriched 15NH4Cl,
4 g/L 13C6-glucose and 100 mg/L of ampicillin. MsrB1 and
Trx were expressed, by growing host cells at 37◦C until
an OD600 reached 0.8, followed by induction of protein
synthesis with 1 mM IPTG and subsequent incubation for 3 h
at 37◦C. Cells were harvested by centrifugation and disrupted
by sonication in 50 mM phosphate buﬀer, pH 8.0, containing
400 mM NaCl, 0.01% Tween 20 (Sigma Aldrich); 5 mM
β-mercaptoethanol as well as complete protease inhibitor
cocktail (Roche) (1 tab for 50 mL).
Cell extract was clariﬁed by centrifugation and ﬁltering
through 0,45 μm ﬁlter. Clear supernatant was loaded onto
the preequilibrated in binding buﬀer (50 mM Na phosphate
buﬀer, pH 8.0, 400 mM NaCl, 5 mM β-mercaptoethanol,
and 5 mM imidazole) Ni-NTA column (Novagen). The
column was step-washed with the increasing concentration
of imidazole (5, 10, and 20 mM) in binding buﬀer followed
by elution of protein with 250 mM imidazole in binding
buﬀer. The purity of the samples was examined with SDS-
PAGE gel (Invitrogen). The yield of the proteins per liter of
growth medium was 20 mg and 10 mg for MsrB1 and Trx,
respectively.
The obtained reduced MsrB1 was further subjected to
oxidation by excess of dabsyl-Met-R-SO (kindly provided by
Professor H-Y. Kim) for 3 h at 25◦C in 20 mM phosphate
buﬀer, 20 mM NaCl, and pH 7.5. The ﬁnal NMR MsrB1ox
and Trxred samples contained 1,5–2 mM of protein in 10 mM
NaCl, 10 mM phosphate, pH 5.5, 90%H2O, 10% D2O buﬀer.
The sample for the backbone assignment of reduced double
enriched Trx (15N- and 13C) also contained 5 mM DTT.
2.3. NMR Spectroscopy. All NMR spectra were recorded
at 298 K either on Bruker Avance 600 MHz spectrometer,
equipped with 5 mm z-gradients TXI (H/C/N) cryoprobe at
the NMR centre of NT faculty, NTNU or Varian DirectDrive
NMR System 700 MHz spectrometer, equipped with 5 mm
z-gradients salt tolerant H/C/N probe at the SPbSPU. Proton
chemical shifts were referenced to external 3-(trimethylsilyl)-
propane-sulfonic acid sodium salt (DSS), while 15N and
13C chemical shifts were referenced indirectly to a liquid
ammonia and DSS, respectively, based on the absolute
frequency ratios [34].
The comparison between reduced and oxidized forms
of MsrB1 was performed by analyzing 2D 15N-1H HSQC
spectra of both reduced and oxidized MsrB1. The spectra
were acquired using pulse sequence from the standard pulse
sequence library. N-H coupling constant was set to 90 ms, the
relaxation delay in HSQC experiments was of 1 s. 2048 com-
plex points were collected in F2 dimension, while 256 were
collected in F1 dimension. 32 scans per each transient have
been recorded.
1H, 13C, and 15N backbone resonance assignments
for Trx protein were achieved using 15N HSQC, HNCA,
CBCA(CO)NH, CBCANH, HBHANH, HBHA(CO)NH,
and 15N NOESY NMR spectra from the standard pulse
sequence library.
The NMR data were processed with the BRUKER XWin-
NMR version 3.5 and Varian VNMRJ version 2.2C software.
Spectral analysis was performed using CARA version 1.8.4.2
[35].
In order to map the interacting sites of both Trx and
MsrB1 proteins, that is, to determine which aminoacids are
involved in the formation of the interprotein complex, NMR
titration of each protein was performed. 15N-1H HSQC
of 15N labeled oxidized MsrB1 was recorded followed by
acquisition of the series of HSQC spectra of oxidized MsrB1
in the presence of increasing amounts of 15N-unlabeled Trx.
Likewise, the 15N-1H HSQC spectrum of 15N-enriched pure
Trx was recorded ﬁrst, followed by the set of HSQC spectra of
Trx containing an increasing amount of unlabeled oxidized
MsrB1. All titration experiments were carried out three times
at 298 K at two diﬀerent pH values 5.5 and 6.5 in order to
have statistically signiﬁcant results.
2.4. Molecular Modelling. Structural calculations for MsrB1
and Trx and their complex were performed using molecular
modelling techniques, including molecular mechanics and
protein docking (Molsoft ICM Pro 3.6 program package
[36], ECEPP/3 force ﬁeld [37]) as well as molecular dynamics
simulations (GROMACS program package version 4.0.7
[38], G53a6 force ﬁeld [39]). VMD [40] and ICM Pro 3.6
program packages were used to visualize and analyze molec-
ular dynamics (MD) trajectories and the resulting averaged
spatial structures of the proteins and their complexes. The
initial sets of atomic coordinates of the proteins (reduced
forms) were taken from PDB (2kv1 and 3trx for MsrB1 and
Trx, resp.).
MD simulations were carried out using a standard
protocol including the following steps: energy minimization,
water box equilibration, and productive run. Both structures
of MsrB1 protein and four complexes of its oxidized form
with reduced Trx were placed in dodecahedral water box.
The box dimensions were chosen in such a way that water
shell around the protein structures was no less than 12 A˚.
Water molecules were represented by SPC model [41]. The
intrinsic MsrB1 positive charge was neutralized with two
Cl− ions, and the negative charge of the protein complex
was neutralized by three Na+ ions. The energy minimization
procedure was executed with steepest descent method. Dur-
ing 300 ps equilibration of the water molecules surrounding
protein, spatial position of its atoms was constrained. The
equilibration procedure was followed by two productive runs
with 5 ns and 20 ns in order to separate proteins and their
complexes, respectively. Distances between Zn2+ ion and Sγ
atoms of the coordinating cysteines of MsrB1 (Cys23, Cys26,
Cys71, and Cys74) were restricted with help of harmonic
potential having a minimum at a value of 2.35 A˚. The
averaged molecular structures were obtained by the cluster
analysis [42] after each productive run of MD.
MD integration step was equal to 2 fs. LINCS algorithm
[43] was used to constrain the covalent bond distances and
the valence angle values. The temperature of the system was
held at 300 K with velocity-rescale algorithm [44]. To hold
system pressure at 1 atm value, Berendsen barostate [45]
with the time constant for coupling, τ = 0.5 ps was used.
Long-range electrostatics was calculated with PME method
[46]. The cut-oﬀ distance of nonbonded interactions was
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set to 10 A˚ for van der Waals interactions and to 14 A˚ for
electrostatic interactions.
To obtain the disulﬁde bond between Cys95 and Cys4
residues in oxidized MsrB1, MD simulations in explicit
water box with the described above protocol were used,
except that the distance between Sγ atoms of two cysteines
was restrained at 2.8 A˚ with the force exceeding van der
Waals repulsion of these atoms. The disulﬁde bond itself
was formed and its geometry was optimized by molecular
mechanic procedures in ECEPP/3 force ﬁeld implemented in
ICM Pro 3.6 program package. To construct the mutant form
Cys35Ser of Trx, the side chain of the mutated aminoacid
together with its neighbours situated within 5 A˚ radius, were
subjected to the energy minimization procedure in ECEPP/3
potential. The average structures of oxidized MsrB1 and
reduced Trx have been subsequently subjected to the protein-
protein docking in ICM Pro 3.6. This algorithm uses optimal
docking area parameter representing the protein surface
regions with the maximum dehydration energy arising upon
formation of the tight protein-protein contact. To reduce
conformational sampling calculations, only the “hot points”
that were situated near MsrB1 and Trx active sites were used
within the study. Interaction energies were calculated using
potential grids with 0.5 A˚ cells, and the truncated van der
Waals potential with maximum 1.0 kcal/mol was used.
The conformations of MsrB1-Trx complex, obtained
from docking, having a representative distance between Sγ
Cys95 of MsrB1 and Sγ C32 of Trx less than 10 A˚, were taken
for further analysis and sorted into four groups depending
on the mutual orientations of the two proteins. Then, the
representative conformations from each of four groups were
reﬁned by the above-described molecular dynamics simula-
tion methods.
3. Results and Discussion
3.1. Assignment of Oxidized MsrB1. Upon oxidation, MsrB1
undergoes structural changes caused by the intramolecular
Cys95/Cys4 disulﬁde bond formation [25]. In order to assign
1H and 15N NMR spectra of the oxidized MsrB1, the HSQC
spectra of MsrB1 protein in both oxidized and reduced states
were compared [25, 47].
This analysis revealed close similarity between the HSQC
spectra of both redoxed forms: the majority of the cross-
peaks assigned in the case of reduced MsrB1 protein re-
mained either at the same position in 1H-15N HSQC spectra
or their positions were slightly altered. This overall spectral
correspondence between reduced and oxidized forms of
MsrB1 allowed us to unambiguously identify and assign the
cross-peaks related to the most of the aminoacids of the
oxidized MsrB1. Nevertheless, the signal broadening and
the shift of some of the cross-peaks in the oxidized protein
corresponding to the residues either belonging to the
protein active site or situated in its vicinity were observed
(Cys4, Phe82, Cys95, and Ile96). The performed comparison
provided us with the assignment of the 1H and 15N chemical
shifts of oxidized MsrB1 protein and indicated that no major
structural changes occur in MsrB1 protein upon oxidation.
3.2. Assignment of Reduced Trx. The protein’s backbone
assignment was performed using a standard procedure. The
availability of the assignment of native human Trx (313 K,
pH = 5.5) [48] assisted in the obtainment of the present
assignment. As a result, 95% of all Trx aminoacids were
identiﬁed and assigned in the present study. The backbone
assignments of Trx’s 1H, 13C, and 15N nuclei were deposited
in BioMagResBank under accession number BMRB-16850.
The obtained within the study assignments for both oxidized
MsrB1 and reduced Trx provided a basis for our further
investigations on interaction between Trx and MsrB1.
3.3. Monitoring of Interaction of Oxidized MsrB1-Trx. NMR
spectroscopy is a commonly used technique for mapping
the interacting site of a protein upon complex formation
with its ligands. Within the study, it was performed the
NMR titration of oxidized MsrB1 with reduced Trx and vice
versa. To determine whether the interaction of these proteins
can be observed on NMR time scale and, in the positive
case, to determine which aminoacids from those proteins are
involved in the interaction, the following approach was used.
15N-enriched protein (either MsrB1 or Trx) was titrated with
nonenriched partner, and their interaction was monitored
by comparative analysis of 1H-15N HSQC spectra of a single
protein and the protein in the presence of its partner.
Since only one protein was enriched with 15N NMR active
isotope in each single experiment, the presence in solution
of another protein did not hamper the observation of 1H-
15N spectrum under analysis, and it was possible to clearly
identify aminoacids changing their NMR parameters (either
chemical shifts (shifting of the cross-peak) or relaxation rates
(broadening of the cross-peak)), which indicated that these
residues are involved in interaction with another protein.
This analysis allowed us to determine which aminoacids
from each protein are directly involved in the complex
formation.
3.4. The NMR Titration of Oxidized MsrB1 with Reduced
Trx. The titration of MsrB1 revealed its aminoacids involved
in binding with Trx. The integral chemical shift diﬀerences
calculated for all MsrB1 residues using the relationship
Δ1H + Δ15N/7 (Δ1H + Δ15N/5 for glycine residues) [49] and
plotted as a function of the aminoacid number, are shown in
Figure 1(a). These data show that the residues belonging to
the MsrB1 active site as well as their neighbouring residues
directly participate in interaction with reduced Trx (C4-F7,
E65, and C95-F97). It was also observed that the MsrB1
HSQC cross peaks corresponding to the residues revealing
the maximal shifts upon interaction with Trx became broad-
er (increase of transverse relaxation rates), thus supporting
our ﬁnding in pinpointing of the interaction relevant ami-
noacids. Altogether, our studies indicate that these MsrB1
residues are involved in protein complex formation with Trx.
3.5. The NMR Titration of Reduced Trx with Oxidized MsrB1.
The integral 1H-15N HSQC chemical shift diﬀerences for
all Trx residues plotted as a function of the aminoacid
number were obtained as described above and are shown in
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Figure 1: (a) Chemical shift diﬀerence observed for each residue of MsrB1 upon NMR titration by Trx. Lower panel shows in red the residues
belonging to the protein active site revealing maximal changes upon titration. (b) The 3D structure of oxidized mammalian MsrB1. “Hot
points” used for molecular docking are evidenced in red.
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Figure 2: (a) Chemical shift diﬀerence observed for each residue of Trx upon NMR titration by MsrB1. Lower panel shows in red the residues
revealing maximal changes upon titration. (b) The 3D structure of oxidized mammalian Trx. “Hot points” used for molecular docking are
evidenced in red.
Figure 2(a). The titration of Trx has revealed three aminoacid
areas which are involved in interaction with MsrB1: D26-S35,
V57-E68, and K72-M74. These segments are evidenced in red
on the lower panel of Figure 2(a). Our results indicate that:
(i) Trx active site (as expected) is involved in the interaction;
(ii) the monitored segments are situated mostly on the Trx
external loops; (iii) these segments are rather close in space,
thus supporting and validating our ﬁndings.
3.6. Structural Modelling of Oxidized MsrB1 and Reduced
Trx. The average structures of oxidized MsrB1 and reduced
Trx were obtained from the molecular dynamics simulations
starting from coordinates of the reduced proteins taken from
PDB (2kv1 and 3trx for MsrB1 and Trx, resp.). The calculated
structures are shown in Figures 1(b) and 2(b).
3.7. Docking of Oxidized MsrB1 and Trx. Upon formation of
an intermolecular protein complex, catalytic Cys32 (active
residue) and Cys35 (resolving residue) of Trx should become
close in space to the disulﬁde bond, connecting Cys4 and
Cys95 residues of oxidized MsrB1. Such arrangement makes
possible that Cys32 of Trx attacks the MsrB1 disulﬁde bond.
A protein docking procedure was carried out in order to
identify possible options for mutual arrangement of these
proteins. Based on the above-mentioned distance restrains
and experimental NMR data, the “hot points of docking”,
were found (evidenced for both proteins in Figures 1(b)
and 2(b) in red), and more than 1000 spatial structure
orientations were generated. Our experimental data on
residues involved in complex formation and application of
10 A˚ distance restrains between the Sγ atoms of Cys32 of Trx
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Table 1: Structural parameters for MsrB1-Trx complexes (four groups) revealed by protein docking. The distances between sulphur atom
of Cys32 of Trx and the nearest sulphur atom of MsrB1 disulﬁde bond as well as three pairs of the nearest aminoacids approaching in space
for each group (to outline the spatial orientation of the proteins within a complex) are presented.
Group A Group B Group C Group D
Distance, A˚ (Trx Cys32)
S/S–S bond (MsrB1)
7,1 7,8 7,8 5,3
Nearest neighbouring contacts between residues
MsrB1 residues W43 H39 P87 S2 W43 P87 W43 N62 P87 F6 P42 R93
Trx residues M37 E95 S90 W31 A92 E70 M37 K72 K96 K72 D60 K36
(A) (B) (C)
(a) (b) (c)
C
C
C
N-term
R93
I96
N-term
S5
I96 F7
S98
Figure 3: The snapshots (A, B, and C) of the protein complex formation along the molecular dynamics trajectory. The panels (a), (b), and
(c) show zoomed views (interactions interfaces) of the snapshots (A) and (C), respectively.
and Cys4-Cys95 disulﬁde bond of MsrB1 were used to sort
these structures into four groups. The neighbouring contacts
between residues and the distances between sulphur atom of
Cys32 (Trx) and the nearest sulphur atom of oxidized MsrB1
disulﬁde bond, diﬀerentiating each group, are shown in
Table 1.
Among the four represented complexes, the fourth (D) is
the most plausible since the distance in this structure be-
tween Cys32 of Trx, and two sulphur atoms of disulﬁde bond
in MsrB1 were found to be minimal (5.3 A˚). Further, each of
the four representative structures has been subjected to 5 ns
molecular dynamics simulations.
3.8. Molecular Dynamics Procedure. The aim of the molecu-
lar dynamics simulation was to reﬁne the possible structure
of the Trx-MsrB1 complex taking into account the obtained
NMR data, the eﬀects of water environment, and ﬂexibility
of proteins backbone and side chains. The analysis of the
averaged structures of the complexes obtained after 5 ns
of MD simulations reveal that only for complex D the
distance SγCys32 Trx–SγCys4 MsrB1 remains the smallest
among all possible complexes. Therefore, the MD trajectory
for this complex was extended to 20 ns (Figures 3(a) and
3(c)). It is necessary to emphasize that even if these data
suggest that the SγCys32 Trx is closer to SγCys4 of oxidized
MsrB1, the analogous distance to Cys95 is rather compa-
rable. This observation precludes us to determine which
Cys residue from intramolecular MsrB1 disulﬁde bridge will
be subsequently targeted to form intermolecular disulﬁde
bond.
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As it was calculated by our MD, the N-terminal tail of
MsrB1 upon oxidation gets closer to the β-strand of the pro-
tein formed by Arg93-Ile96 (Figures 3(A) and 3(a)). Fur-
ther, elongation of the mentioned MsrB1’s β-strand occurs
additionally involving residues I96-S98 accompanied by
formation of three additional hydrogen bonds with residues
S5-F7 (Figures 3(B) and 3(b)). This newly constituted strand
belongs to the N-terminus of MsrB1, which now is stabilized
by the intramolecular disulﬁde bond formed upon oxida-
tion. At the ﬁnal stage of the interaction, Trx adjusts its
unstructured loop to the newly formed N-terminal β-strand
of MsrB1, leading to formation of interprotein β-sheet,
composed of six β-strands, where ﬁve of them belong to
MsrB1 and the sixth to Trx (residues K72-M74) (Figures
3(C) and 3(c)). Thus, in developing of two new β-strands
(one intramolecular MsrB1 and one intermolecular), nine
aminoacids participate. This observation is in good agree-
ment with our NMR titration results (Figures 1 and 2), thus
further validating our calculations. In addition, β-strand of
MsrB1 formed by G77-F82 extends periodically to residues
G75-G77 allowing residues G75-L78 to form hydrogen
bonds with the second antiparallel β-strand of MsrB1
constituted by A66-G72. The distance between SγCys32 of
thioredoxin and SγCys95 of MsrB1, a reference distance,
oscillates during the interaction from the smallest value of
about 3.2 A˚ (ﬁrst 100 ps of the trajectory) to 9.5 A˚ and then
down to 4.8 A˚. Such approaching may cause a catalytic act,
upon which the disulﬁde bond becomes resolved followed by
reduction of MsrB1.
Upon the formation of the protein intermolecular com-
plex, six new hydrogen bonds evolve (three of them are
interproteins), thus stabilizing the intermolecular complex.
Analysis of MD trajectories for MsrB1-Trx complex (prior
formation of the intermolecular disulﬁde bond) indicates
an existence of two conformations of C4-C95 MsrB1 bond.
The disulﬁde bond in both conformations is strained in
diﬀerent extent. The degree of strain could be estimated by
comparison of the energies for the van der Waals (vw) and
torsion (to) terms of disulﬁde bond for oxidizedMsrB1 in the
step preceding the complex formation and in the free state. In
accordance with ECEPP/3 force ﬁeld, the following energies
have been obtained (kcal/mol): 3.1 and 3.2 (vw), −0.5 and
−1.7 (to), 2.6 and 1.5 (total) for “strained” and “relaxed” S–
S bond, respectively. It is worth to mention that during the
MD simulations this MsrB1 intramolecular S–S bond prefers
its “strained” conformation. This bond thus becomes totally
destabilized by 2.6 kcal/mol for “strained” or by 1.5 kcal/mol
for “relaxed” conformation. However, the presence of six
hydrogen bonds inside the developed interprotein β-sheet
obviously overcompensates the straining of Cys4-Cys95
bond in MsrB1, as energy proﬁt from one hydrogen bond
formation in β-sheet can be estimated by −0.78 kcal/mol
[50]. Therefore, the formation of the interprotein MsrB1-Trx
complex becomes energetically preferable.
4. Conclusions
In this study, both the experimental and the computational
approaches were combined to investigate MsrB1-Trx protein
complex formation. Through the analysis of the NMR data,
the aminoacids involved in protein complex formation have
been determined. The average 3D structures of oxidized
MsrB1 and reduced Trx were generated and subsequently
subjected to protein docking and molecular dynamics. Com-
plementary use of the mentioned approaches indicates that
the formation of the interprotein β-sheet, stabilized by new
hydrogen bonds, distorting the MsrB1 intramolecular disul-
ﬁde bond. This disulﬁde bond straining favours the forma-
tion of intermolecular disulﬁde bridge of MsrB1-Trx com-
plex. The study evidences structural and energetic driving
forces of MsrB1-Trx complex formation.
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In this review, we aim to summarize the data about evolution, sequential, structural and 
coordination peculiarities of the MsrBs family representing important redox proteins without 
taking into consideration their catalytic mechanisms. 
I. Methionine residue in proteins: its oxidation and reduction 
All amino acids found in proteins are susceptible to oxidation. However, only two of them, 
sulfur-containing cysteine and methionine, can be reversibly oxidized. Along with tryptophan 
these residues are the most susceptible to oxidation (1). The process of methionine (Met) 
oxidation consists of two steps (Fig.1). During the first step, Met is reversibly oxidized to 
methionine sulfoxide (MetO). Methionine sulfone is the product of a deeper, irreversible 
oxidation of MetO during the second step. Methionine oxidation can be caused either by 
physiological agents, like superoxide, hydrogen peroxide, hydroxyl radicals (termed as 
reactive oxygen species – ROS), hypochlorous acid, chloramines and some of the metal ions 
(as copper and iron). Physiological oxidants are also capable to carry out Met oxidation. 
These include either reactans able to oxidize all amino acids (2, 3), or hydrogen peroxide, 
chloramine T, N-chloro-succinimide and dimethyl sulfoxide, which oxidize Met rather 
selectively (1, 4). It was found that the ability of Met to be oxidized strongly depends on its 
solvent exposure (5). Indeed, surface-exposed residues are more readily oxidized, than the 
ones hidden inside the protein’s structure.  
Living organisms developed a defence system against unwanted protein oxidation which 
includes the reduction of reversibly oxidized amino acids (Cys and Met) as well as the 
removal of the  irreversible oxidation products from the cell. Methionine sulfoxide reductases 
(Msrs), being part of this system, can reduce both free or protein-bound methionine sulfoxide 
back to methionine (Fig.1) (2, 6). Msr genes are found among the most conserved in almost 
all kindoms of life (7, 8).  
The reversibility of Met oxidation can be seen from different points of view. First, surface-
located Met residues, being exposed to the ROS attack, reduce the free radicals cellular level, 
thus, acting as endogenous antioxidants (4, 5). Second, oxidation of some Met residues may 
leads to loss of enzyme activity, thus Msrs reduction of such residues allows the protein 
recover their finctions (9). Finally, the process of periodic oxidation/reduction of Met in 
proteins plays a regulatory role inhibiting or inducing some physiological events. For 
example, functional role of the methionine oxidation in regulation of the Shaker voltage 
dependent K+ channels was examined (10, 11). The results show that Met oxidation and 
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reduction facilitated by MsrA regulate the channel inactivation time course. Another example 
is the calcium-binding protein – calmodulin. Oxidation of one of the calmodulin Met residues 
results in a 30-fold decrease in the ability of the protein to bind calcium (12). Additional 
studies have shown that this decrease can be reversed by the addition of MsrA (13). It was 
suggest that the reversible oxidation of specific Met residues in calmodulin may regulate its 
activity and calcium cell homeostasis (9, 10, 14). 
II. Different classes of Msrs 
There are two main classes of Msrs: MsrA – which can reduce protein-bound or free S-
epimer of methionine sulfoxide (15-21) and MsrB – which reduce both the protein-bound R-
epimer of MetO, and, with less efficiency, free R-MetO (Fig.1) (22-25). Since each of the 
Msr classes has its own, different from each other three-dimensional fold, and significantly 
distinct, well conserved amino acid sequence it is possible to refer to the convergent 
evolution for MetO reduction in living organisms (7, 26-28). MsrA protein sequences, are 
characterized by the invariable signature motif “GCFWG/C’’ (1, 29, 30) and MsrB - 
“RXCXN” (where X indicates any amino acid) or in case of MsrB1 - “RXUXF” (Fig.2, 
underlined with the dash line) (6, 8, 27). Structures of some archaea, bacterial and eukaryotic 
MsrB proteins have previously been determined using either X-ray or NMR techniques 
(Table 1, Fig.3).  
The overall structural comparison of the MsrB family was reported earlier (31, 32). It was 
emphasized that the central cores of all proteins in the family are well conserved. However, 
while bacterial MsrB and mammalian MsrB2 have both Į-helix and ȕ-sheets as structural 
elements, MsrB1 represents a more flexible structure containing only ȕ-sheets (Fig. 3).  The 
detailed structural comparison of MsrB proteins is reported in the chapter “V. MsrB structural 
description”. 
Both MsrA and MsrB were found in the most genomes (8), however, their distribution within 
the life kingdoms is quite different. Without exception, all studied eukaryotes and 
cyanobacteria contain msrA and msrB genes (28). In prokaryotes, MsrA and MsrB genes can 
form two separate transcription units (7), with not adjacent loci on the chromosome. 
Alternatively, genes can either be transcriptionally (33) or translationally fused and form in 
the last case  the two-domain protein - MsrAB (34). In prokaryotes, the Msrs distribution is 
rather variable: in some thermophile or anaerobic archaea no Msrs are present. Some 
organisms possess both Msrs, while others only MsrA but no MsrB. However, there are no 
MsrB-containing organisms which would also not contain MsrA (28). A possible explanation 
for the different MsrA/MsrB distribution in diverse organisms might be the existence of an 
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enzymatic stereospecific preference for S-epimers during Met oxidation in cells, or, 
alternatively, a more damaging effect of S-MetO for the cell. Otherwise, MsrA and/or MsrB 
might have other unknown biochemical functions along with protein repair, which would 
account for their unequal distribution in genomes (28).  
The number of msrA and msrB ortholog copies also greatly varies in the different organisms. 
For example, E.coli contains one copy of msrA and msrB, Arabidopsis harbors five msrAs 
and nine msrBs, Rhizobium meliloti has three msrA and three msrB genes, while mammals 
have one msrA and three msrB genes, i.e. MsrB1, MsrB2 and MsrB3 (8, 14, 20, 25, 35, 36). 
Gene duplication is a frequent event in genome evolution across all three domains of life. The 
organism’s necessity to have alleles expressed under different conditions might be a possible 
explanation of this fact (7, 37-39).   
III. MsrB subcellular distribution in eukaryotic cells  
In eukaryotic cells, specific metabolic reactions (defense against ROS attack (40)) take place 
within different intracellular compartments. For this reason most proteins are allocated to 
only a single cellular location and, thus, need some structural information for their correct 
targeting (41). Mitochondrial and endoplasmic reticulum (ER) targeting sequences (mTS and 
erTS, respectively) are usually placed on the N-terminus of proteins, nuclear TS (nTS) are 
often distributed internally, and peroxisomal TS are located at the C-termini. It has been 
proposed that the N-terminus of the polypeptide that bears mTS attaches to specific 
mitochondrial membrane receptors and initiates its translocation before the complete protein 
is folded (41, 42). Subsequently, the signaling sequence is cleaved from the polypeptide and 
excreted in the endoplasmic membrane for digestion. 
Mammals have three MsrBs: MsrB1, MsrB2 and MsrB3 proteins that are localized in 
different cellular compartments (Table 2) (25). MsrB1 is a cytosolic and nuclear protein, 
MsrB2 is translocated into mitochondria while MsrB3 occurs in the ȿR and mitochondria 
(25). Alternative splicing is a conserved mechanism to regulate subcellular distribution of 
methionine sulfoxide reductases in mammals and other animals (43). The distribution of 
MsrB3 will be discussed further.  
MsrB1, the most abundant and active MsrB protein in mammals, is present in cytosol and 
nucleus (25). nTS consists of one or two short sequences that are rich in positively charged 
amino acids (e.g. Lys and Arg). Nuclear localization signals can be located anywhere in the 
protein, but usually form patches or loops on the protein surface. Although MsrB1 does not 
have clearly predictable nuclear TS, it is rich in positively charged residues, which could 
serve to transfer the protein into the nucleus.  
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Both MsrB2 and MsrB3B form of MsrB3 are targeted to mitochondria. Normally, 
mitochondrial TS are represented by about 20–60 amino acid residues with abundant positive 
charges and frequent hydroxylated residues (41). Targeting sequences are predicted to form 
amphipathic Į-helices in membranes or in membrane-like environments, whereas in aqueous 
solution they show little structural organization (44-48). Mouse MsrB2 contains a typical 
mitochondrial signal with the high proportion of arginine residues at the N-terminus 
(MARLLRALRGLPLLQAPGRLARG)  (25). 
MsrB3 should be considered separately. In humans and other species (e.g. zebrafish) MsrB3 
were found to be translated in both ER (MsrB3A) and mitochondrial (MsrB3B) forms due to 
alternative splicing that produces contrasting ER and mitochondrial signals (25). It should be 
noted, that the mitochondrial location of the human MsrB3B, was not immediately clear 
because it had contrasting N- and C-terminal signals (49): on the N-terminus – mitochondrial 
and on the C-terminus – KDEL-like ER signal (Fig. 2, ER signal underlined with black line) 
(25). In contrast, rodents (rat and mouse) have only one form of MsrB3 found only in the ER 
(49). At the same time, mouse MsrB3 has both ER and mitochondrial signal peptides at the 
N-terminus: the mitochondrial signal is located between the ER signal and the common MsrB 
domain (Table 1). The role of the mouse MsrB3 mitochondrial signal, which is functional if 
placed as an N-terminal sequence, remains unclear and requires further research (49). 
MsrB3A and rodent MsrB3 are targeted to ER with C-terminus (KDEL-like) ER retention 
sequence (KAEL for human and RAEL for mouse MsrB) (25, 49). 
It follows from the above discussion, that oxidized methionines can be repaired in different 
cellular compartments in mammals. Mitochondria, the major source of ROS in the cell, have 
two different MsrBs: MsrB2 and MsrB3B. MsrB2 is the most active at lower concentrations 
of Met and inhibited by high concentrations of the substrate, whereas MsrB3B is most active 
at concentrations of methionine sulfoxide more than 1mM (25). In addition, these two MsrBs 
show differential tissue expression (50). The above argumentation can probably explain the 
occurrence of two MsrBs in mitochondria. 
IV. Selenocysteine in Msrs 
Selenocysteine is one of the naturally occurring amino acids in proteins. In this residue, that 
is a cysteine analog – sulfur is replaced by selenium. These two elements have a similar 
electronegativity (2,58 for sulfur and 2,55 for selenium (51)), however, Se is a stronger 
nucleophile (52-54). Furthermore, the pKa of selenocysteine is more acidic than that of 
cysteine (pKa (Sec) = 5.2–5.6 while pKa value of Cys is around 8.3) (51, 53). This means that 
at physiological pH the Sec residue will be deprotonated (anionic form) and more reactive, 
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while the cysteine residue would still remain protonated. Several oxidoreductases including 
glutathione peroxidase, thioredoxin reductase, methionine sulfoxide reductase, have 
selenocysteine (Sec) in their active sites (55). Due to the higher selenium nucleophilicity, 
selenoproteins are typically more active than their cysteine (Cys) mutants (56). This high 
catalytic activity has been regarded as a key reason why Sec is used in biological systems 
(57-60). However, the nearest protein environment of Cys or Sec, as well as the overall 
structure of the protein can significantly influence the redox potential of both residues, and 
the small changes in the amino acid composition in the region close to the  active site can 
lead to comparable catalytic efficiency of the sulfur homolog of a selenium-dependent 
enzyme (61). Taking in account this possibility to have comparable with Se-containing 
proteins activity for Cys-analogs, only a higher activity of selenoproteins cannot be unique 
reason to use Sec instead of Cys. Thus, Sec utilization by living organisms is the 
compromise. On the one hand, Sec utilization provides higher activity, a broader range of 
substrates and of microenvironmental conditions (e.g. pH) in which enzyme is active. On the 
other hand, it exists the limitation imposed by electron donors (or acceptors depending on the 
reaction), dependence on selenium, and the availability and complexity of the Sec insertion 
system (61). It is worth mentioning, that the S to Se replacement may also completely change 
the protein’s function (55). For example, a Sec-containing form of subtilisin or glutathione S-
transferase converts these proteins into a peroxidase (58, 62) 
Seleno-containing MsrBs are found in invertebrates and vertebrates, but not in bacteria or 
plants (8, 63). In contrast, selenoprotein forms of MsrA are also found in bacteria and lower 
eukaryotes, including a unicellular green alga (63-65). Mammals have one selenoprotein 
MsrB (MsrB1) and two Cys-containing homologs (MsrB2 and MsrB3). The MsrB1 contains 
selenocysteine in the place of the catalytic cysteine residue normally present in other MsrBs 
(Fig.2, Cys95 and Sec95 shown in red) (8, 25). MsrB1 is the most active in the reduction of 
MetO among all members of the MsrB family. The mechanism of a catalytic MetO reduction 
by Msrs employs a sulfenic acid chemistry and S-S/Se-S formation (66-70). Upon reduction 
of methionine sulfoxide MsrBs get oxidized forming an intramolecular disulfide/selenide-
sulfide bond. The second step of the MsrBs biological cycle includes its reduction or, in other 
words, the reduction of the S-S/Se-S bond. Thioredoxin (Trx) is generally thought to be a 
natural reductant for MsrBs (68, 70-72). The Se-S bond is characterized by a lower potential 
and can be more challenging for reduction than the S-S bond (55). MsrB1 has highly 
conserved regions that distinguish it from the cysteine-containing MsrBs and can facilitate 
the MsrB1ox reduction. Fig. 2 illustrates a multiple-sequence alignment of MsrBs, and reveals 
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a set of conservative regions in MsrB1 with respect to other MsrBs. Recently, the simulation 
of the Trx-MsrB1 interaction dynamic was published (73). NMR titration and molecular 
dynamics simulations established which MsrB1 amino acids are involved in the initial 
interaction with Trx (Fig.2, underlined with blue lines and black rectangle). These include the 
S5-F7, P42, A66-G72, G75-F82 and R93-S98 amino acids. The sequence alignment shows 
that all these amino acids groups belong to well conserved MsrB1 regions. In addition, their 
composition is significantly different from non-selenium MsrBs. The spatial arrangement of 
these groups is shown in Fig.4 (in orange color). It therefore appears that in the course of 
evolution the amino acid composition of the Se-containing MsrB1 changed, due to a 
facilitated Se-S reduction by Trx. Indeed, the selenoprotein MsrB1 is a better substrate for 
Trx than Cys-containing MsrB2 and MsrB3 proteins (55). 
V. MsrB structural description 
All structurally characterized MsrB (both mammalian and bacterial) have a highly similar ȕ-
fold consisting of two ȕ-sheets, one with three strands and another with five strands (Table 1, 
Fig. 3). However, the mammalian MsrB2 protein and bacterial MsrBs additionally have 
several Į-helices at the N-terminal part of the protein. A common feature of these Į-helices is 
that they are not rigidly fixed to the ȕ-strand core structure. It was suggested that these 
helixes might assist for interaction of MsrBs with different substrates (31). The latter 
structural feature is absent in MsrB1 protein. From the sequence alignment of different 
MsrBs it appears that the selenoprotein MsrB1 is the smallest and the most compact among 
MsrBs (31, 74). MsrB1 is characterized, as it was shown by recent NMR studies by the 
presence of mobile N- and C-terminus tails (31). The mobility of N-terminus is extremely 
important because this tail is involved in catalytic activity of the MsrB. Indeed, Cys4, situated 
at the N-terminal tail, plays role of a resolving cysteine at the methionine sulfoxide reduction. 
An interesting aspect of the evolution of the MsrB superfamily is the dramatic variability 
with regard to length and secondary structure composition of N- and C-terminal regions in 
these proteins. This can be clearly observed from superimposition of MsrB structures (31): 
while the E-core is well conserved, the terminal parts of the proteins show significant 
differences. This feature is further supported by bacterial MsrBs: although their core 
structures are very similar, their N- and C-terminal regions are not superimposable. 
Therefore, it appears that the evolution of MsrB1 tightly couple the shorter N-terminal region 
which is not characterized by any secondary structure, with the use of N-terminus resolving 
Cys together with the catalytic Sec.   
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Comparative structural analysis of mouse MsrB1 and bacterial MsrBs indicates structural 
differences between selenoprotein and non-selenoprotein MsrBs that result in the different 
mechanisms of the redox reaction catalyzed by MsrBs. These differences may be even 
deduced from the analysis of methionine sulfoxide reductase B secondary structure. The 
presence of the D-helical structures in the N-terminal region of bacterial MsrBs suggests that 
large structural alterations during catalytic act are unlikely in these enzymes due to rigidity 
imposed by D-helices. Instead, the absence of any secondary structure in the N-terminus of 
Sec-containing MsrB1 does not impose any rigidity constraints. As the result, the catalytic 
reaction in Sec-containing MsrB1 occurs through the formation of internal selenide-sulfide 
bridge between the catalytic Sec and the resolving Cys situated on mobile N-terminus, while 
the reaction between methionine sulfoxide and other MsrBs occurs through formation of 
sulfenic acid intermediate and any disulfide bridge is formed within this reaction (55). Such 
peculiarities of catalytic reactions between Sec- and Cys-containing proteins are the result of 
evolutionary changes of catalytic Cys to Sec accompanied by other adaptations such as 
distinct resolving Cys and flexible N-terminus.  
It should be also noted from structural comparison of MsrBs proteins (Fig.3) that mammalian 
MsrB2 is more similar to bacterial MsrBs rather than to mammalian MsrB1 as it contains 
three D-helices on the exterior of the protein in the N-terminal region. Indeed, the proposed 
catalytic mechanism for mammalian MsrB2 protein is the same as that proposed for bacterial 
MsrBs (32). This observation indicates that the functional similarities within MsrB family are 
determined not by organism, but rather by the nature of the catalytic residue and the protein 
secondary structure. 
VI. Zinc ion in MsrB 
Zinc is one of the most important biological metals (75-78). The ability to determine the 
primary protein structure through the translation of DNA sequences now allows the 
prediction of zinc binding sites and, thereby, the enzyme function (79). It is possible to 
distinguish three types of zinc binding sites: catalytic, co-catalytic and structural. For the 
purpose of this review, we will discuss here only the latter two classes. Structural zinc sites 
have four protein ligands and no bound water molecule. There is at least one short spacer 
between coordinating zinc ion residues, generally containing two amino acids (80, 81). 
Cysteines are the most common, but not unique ligands in such sites. The second most 
prevalent ligand is His. Cys and Cys/His- containing sites are also called ‘zinc fingers’. 
However, also Asp and Glu residues are able to bind zinc, even if they perform this task less 
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frequently (80, 82, 83). Multiple Glu/Asp metal binding sites can be too flexible for zinc and 
lead to a weak binding constants due to fast dissociation rates of the zinc ion from such sites. 
The usual presence of Ca2+ and Mg2+ in such acidic ligand sites does correlate with the weak 
binding constants of metal ions for protein binding sites (80). There is an interesting example 
of ligands substitution in adenylate kinases belonging to different organisms. The adenylate 
kinase from Bacillus stearothermophilus contains a zinc-binding site composed of four Cys 
ligands (84). The adenylate kinase from Bacillus subtilis also contains a structural zinc site 
(85). In the latter case, the fourth Cys has been replaced by an Asp residue in this structural 
zinc site. 
 In co-catalytic sites, metals may be important to the overall fold of the protein as well as 
catalytic function. Asp and His predominate as ligands in this type of zinc sites where the 
frequency of coordinating residues occurrence is maximal for aspartate and histidine, and is 
lower for glutamate (80). These sites can also contain unusual zinc ligands such as amide 
carbonyls provided by Asn, Gln and the peptide backbone; hydroxyl groups from Ser, Thr 
and Tyr and the amine nitrogen of Lys or the N-terminal amino acid of the protein (80). The 
ligands are often part of a ȕ-sheet or are provided by amino acids one or two residues before 
or after a ȕ-sheet. A related interesting case was found for the co-catalytic Zn-binding site of 
ȕ-lactamase. The crystallization of ȕ-lactamase from the Bacillus cereus at a pH 5.6 in 0.1 M 
ZnSO4 in a citrate/cacodylate buffer leads to a protein with one Zn ion (86). However, once 
the same protein was crystallized in different, more basic condition (at pH 7.0 in the presence 
of 0.5 mM ZnSO4 in Tris buffer, (87)) the resulting protein contained two Zn ions. Thus, the 
prediction of a Zn binding site based only on the presence of Cys/His ligands cannot give 
complete pictures of the zinc distribution in proteins.  
Sequence analysis of MsrBs homologs shows the existence of proteins with two different set 
of metal binding sites: one with the “classic” four Cys ligands for zinc binding and another 
with different “not classic” amino acids at the correspondent coordinating positions (88). It 
was suggested the existence of a strictly Zn-dependent family of proteins and a family that 
normally has Zn in metal binding site with four cysteines, but it can be expressed also as 
zinc-independent forms where cysteine ligands are substituted by other residues (89). Thus, 
for some protein family the same protein may exist either with zinc or without. A systematic 
genome analysis showed that approximately 20% of the zinc protein families in the Protein 
Data Bank (PDB) have a significant number of zinc-independent forms (zinc-dependent form 
was described as a homolog which preserved three or four known ligands Cys or His, and a 
zinc-independent form was defined by having fewer than three known ligands) (Fig. 6) (88). 
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In another study of the Zur (a repressor of zinc transport regulation in bacteria) (90) it was 
suggested that non-zinc-binding paralogs were expressed under zinc-restricted conditions to 
partially replace the zinc-binding proteins, thereby freeing up some zinc to be used by the 
essential zinc-binding proteins. 
The majority of MsrB proteins have four cysteines that bind Zn ion (30, 91). They include 
MsrB1, MsrB2, MsrB3 and the most part of bacterial MsrB (Fig.2). Some of the bacterial 
MsrB subclasses, however, have only Zn-independent forms (e.g. MsrB domain of MsrAB 
from Neisseriaceae, Bacillus sp. and St. pneumoniae), some have  only Zn-containing forms 
(MsrB from B. pseudomallei, X. campestris) and others -  both forms (MsrB from S. meliloti; 
V. cholera) (unpublished result from (88)). For example, S. meliloti has both Zn-dependent 
and independent forms. In Zn-independent form, four cysteines are substituted by Asp, Ser 
and Gly (Fig.2, dash rectangles). While Asp and Ser can hypothetically bind Zn, no Gly has 
been mentioned as Zn ligand. However, in the immediate vicinity of Gly highly conserved 
His, Asp, Glu and Ser are present and it could be that the latter residues also weekly 
coordinate zinc ion. The same “not classic” ligands are present in MsrB domain of bacterial 
fused MsrAB. 
Several structures of MsrB proteins are presently reported (Table 1, Fig. 5). Some of them are 
characterized by the presence of Zn ion, while other lacks it. From the structural comparison 
(Fig. 5), it is evident that both Zn-containing and Zn-independent forms have identical 
structure of metal binding site among themselves and to the corresponding region of no metal 
homologs. All of them have two unstructured loops between four ȕ-sheets. This region seems 
very well conserved in all the reported structures. It should be noted, that the unpublished 
structure of MsrB1 from Homo sapiens has iron ion in the metal binding site, however all the 
protein’s structural features to the rest of the proteins reported in Fig. 5 remained unaltered. 
In the cases where Zn ion is absent, it is possible that some other bonds and not the Zn ion 
preserve the fold of the region. Some Zn-binding site studies were carried out by different 
laboratories (30, 91). In these studies it was shown that in MsrB from Drosophila and E.coli 
mutation of Cys at the positions 23, 26, 71 and 74 (numbering corresponds to MsrB1 from 
Mus musculus) on GSGS, DSSS and DSSA results in Zn losing by protein. The reversible 
mutation of DSSS pattern to CCCC results in a more stable, Zn-containing protein. It was 
suggested, that the role of the metal in Zn-containing MsrBs is to stabilize the core structure 
and thus, to adopt the active site conformation for efficient reductase activity. However, as it 
was stressed, this assumption is in apparent contradiction with the fact that the bacterial 
MsrB, lacking the two CXXC signatures is as active as the Zn-containing MsrB (91). It was 
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suggested that a more careful analysis of stabilizing elements for MsrBs that do not contain 
CXXC motif should be performed.  
The analysis of the crystallization conditions for the published structures of MsrBs where Zn 
ion is absent (no “classic” Zn-binding CXXC motif) suggests that the crystallization occurs in 
mild acidic environments (27, 92, 93). Some of the “not classical” Zn ligands can be 
protonated at these conditions. As mentioned above, Zn binding can be influenced by the 
solution pH value. In other words, when the Zn ligands are protonated, they are not able to 
coordinate metal ion. In addition, the reported absence of Zn ion for some experimentally 
characterized MsrB may simply be due to the fact that metal ion is lost during the protein’s 
isolation and purification since the coordination bonds between Zn and oxygen containing 
ligands are weaker with respect to usual cysteine ligand. Thus, zinc ion in such cases could 
escape detection. The discussed above structural similarities within metal coordinating loops 
among all MsrBs would indirectly support this suggestion.  
Recently in our laboratory it was demonstrated (94) that Cys containing MsrB1 expressed in 
E.coli in the cobalt-containing M9 media can replace Zn by Co. Paramagnetic Co ion 
insertion can be easily detected by both UV-Vis (Co-containing protein has a characteristic 
light blue color) and NMR spectroscopies (by the appearance of paramagnetically shifted 
signals). It is known (95, 96), that Co ion can be used to substitute Zn ion since the both 
metal ions have similar radii and coordination properties. Thus, the proposed by us technique 
represents an  easy method to check and confirm whether Zn binds only by four cysteines and 
no other ligands at different, more basic pH can coordinate metal ion. 
Summarizing, most MsrBs have four cysteines that bind zinc. It has been assumed that the 
metal binding site plays a structural role in the MsrB family. Some of the organisms have 
also MsrBs proteins, which possess “not classical” cysteine ligands. In such cases, the 
determined structures also report a conserved overall folding that might suggest that the 
proteins still weakly bind metal ion.  
VII. Conclusion 
Living organisms develop efficient and complex defense system against oxidative stress. The 
MsrBs proteins play an important role in this system. They can reduce R-isomer of 
methionine sulfoxide back to methionine. Such reversibility of Met oxidation provides the 
organism the possibility to reduce intracellular level of the ROS, restore the enzymatic 
function of oxidized protein and inhibit or induce certain cellular events.  
MsrBs were found in about all kingdoms of life. The absence of MsrB in some thermophilic 
and anaerobic bacteria may indicate that either the MetO reduction at high temperature does 
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not require a catalyst, or MetO is not produced in significant amounts. Whereas prokaryotes 
have only one type of MsrB, mammals possess three: MsrB1 (the most active mammalian 
MsrB1 containing catalytic selenocysteine), MsrB2 and MsrB3. The use of Sec in proteins 
can represent a compromise between a more active enzyme that can work with different 
substrates at a wider pH range, and the complex genetic mechanism of Se insertion with the 
more challenging Se-S bond reduction. The different eukaryotic MsrBs have peculiar cellular 
distribution to be effectively involved in various redox and other catalytic pathways occurring 
in specific compartments. Mostly MsrBs compartmentalization is achieved by alternative 
splicing and the proteins are imported into the organelles by specific signals. 
Generally, the structure of all catalytic cores of structurally characterized MsrBs is rather 
similar containing two ȕ-sheets. In addition, bacterial MsrBs and mammalian MsrB2 are 
characterized by the presence of N-terminal Į-helixes, while mammalian MsrB1 has only ȕ-
sheets and very flexible N- and C-termini. This flexibility plays an important role in the 
MsrB1 catalysis. The structural difference between mammalian MsrB1 and other MsrB 
proteins is due to evolutionary changes occurred with MsrB class of proteins that also 
presumes different catalytic mechanisms for MsrB1 and other cysteine homologs belonging 
to this class.  
Mostly, MsrBs are Zn-containing proteins. The existence of the metal was predicted by 
bioinformatics based on the presence of two Zn-binding CXXC motifs. However, some of the 
bacterial MsrBs have different well-conserved amino acids at the positions of the four 
cysteines, even if the structures of metal binding site in Zn-containing protein and the 
corresponding region in MsrBs without metal are very similar. Theoretically, there is a 
possibility that Zn can be coordinated by non-cysteine ligands at more alkaline pH and with 
less affinity. Nevertheless, this speculation requires experimental confirmation.   
Thus, in the course of evolution the members of MsrB family developed their amino acids 
sequence and their fold for efficient functioning in different organisms, different cell 
compartments at different environmental conditions. 
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Tables
Table 1. Structural data of MsrB proteins 
Superkingdom / 
Phylum 
Species Method PDB entries Year Ref. 
MsrB 
Proteobacteria Neisseria gonorrhoeae X-ray 1L1D 2002 (27) 
Proteobacteria 
Burkholderia 
pseudomallei 
X-ray 3CEZ /3CXK 2008 (97) 
Archaea/ 
Euryarchaeota 
Methanothermobacter 
thermautotrophicus
NMR 2K8D 2008 UP 
Bacteria 
Streptococcus 
pneumoniae 
X-ray 3E0M/3E0O 2009 (92) 
Proteobacteria 
Xanthomonas 
campestris 
X-ray 3HCI 2009 (93) 
Proteobacteria Neisseria meningitidis X-ray 3HCG 2009 (93) 
Bacteria Bacillus subtilis NMR 2KZN/1XM0 2012 (98) 
MsrB1 
Mammalia Mus musculus, MsrB1 NMR 2KAO/2KV1 2010 (31) 
Mammalia Homo sapience X-ray 3MAO 2010 UP 
MsrB2 
Mammalia Mus musculus, MsrB2 NMR 2L1U 2011 (32) 
MsrB3 – not reported 
UP-unpublished; Ref. - references 
 
Table 2. Subcellular distribution of mammalian MsrBs 
MsrB1 Cytosol, Nucleus MsrB1 
MsrB2 Mitochondria mTS- MsrB2 
Rodent MsrB3 ER erTS-mTS- MsrB3  -RAEL 
MsrB3A ER MsrB3A -KAEL 
MsrB3B Mitochondria mTS- MsrB3B  -KAEL 
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Figure legend 
Fig. 1. Mechanism of methionine oxidation. Step I: reversible oxidation of methione gives two enantiomers: S- 
and R-methionine sulfoxide. Step II: irreversible oxidation of methionine sulfoxide to methionine sulfone. 
Fig. 2. Multiple sequence alignment of proteins belonging to MsrBs family. 
Numbering is consensus sequence with  mouse MsrB1. In abbreviation MsrAB only MsrB domain of protein is 
shown. Conserved catalytic site of MsrBs stressed with black dash line. erTS of MsrB3 underline in black. 
Amino acids from MsrB1 involved in the initial interacting stage with Trx stressed with blue line (73). The 
organisms abbreviation is as follows: NG - Neisseria Gonorrhoeae; NM – Neisseria meningitides; BC - Bacillus 
cereus; HI - Haemophilus influena; HP - Helicobacter pylori; SP - Streptococcus pneumoniae; BS - Bacillus 
subtilis; CO – Clostridium, Alkaliphilus oremlandii; SM147 - Sinorhizobium meliloti SM11, 147 amino acids; 
SM164 - Sinorhizobium meliloti SM11, 164 amino acids; SM135 - Sinorhizobium meliloti SM11, 135 amino 
acids; EC - Escherichia coli; BP - Burkholderia pseudomallei; AV - Azotobacter vinelandii; MT - 
Methanothermobacter thermautotrophicus; HA - Herminiimonas arsenicoxydans; VO - Vibrio ordalii; MM - 
Mus Musculus; HS - Homo sapience; DR - Danio rerio (zebrafish); AT - Arabidopsis thaliana; RN - Rattus 
norvegicus; PA - Pongo abelii; OS - Oryza sativa Japonica Group; BT - Bos taurus. 
Fig. 3. Three-dimensional structures of proteins belonging to MsrB family. 
A – MsrB N. Gonorrhoeae, 3HCH, (27); B – MsrB  X. campestris, 3HCI, (93); C – MsrB1 H. sapience, 3MAO, 
not pubblished; D – MsrB B. subtilis, 1XM0, not pubblished; E – MsrB2 M. musculus, 2L1U, (32); F – MsrB1 
M. musculus, 2KV1, (31). 
 
Fig. 4. Three-dimensional structure of mouse MsrB1, 2KV1,(31). In orange: conserved regions of the Se-
containing MsrB1 involved in the initial stage of Trx interaction (the data taken from (73)).  
Fig. 5. Three-dimensional structure of Zn-binding site and thecorresponding regions of MsrBs family. For the 
explanation see text. A - MsrB1, M. musculus,  2KV1, (31); B - MsrB1, H. sapience, 3MAO, not published; C - 
MsrB2, M. musculus, 2L1U, (32); D  - MsrB, X. campestris, 3HCI, (93); E - B. pseudomallei, 3CEZ/3CXK, not 
published; a – MsrB, N. meningitidis, 3HCH, (93); b - MsrB , N. gonorhoeae, 1L1D, (27); c- MsrB, S. 
pneumoniae 3E0O, (92); d – MsrB, B.subtilis, 1XM0 not published. Blue color: cysteine and “not classic” 
ligands in metal binding site; magenta:  catalytic cysteine. 
 
Fig. 6. Occurrence of Zn-dependent and Zn-independent forms of representative Zn protein families in bacteria. 
Zn (+), organisms only containing Zn-dependent form; Zn (-), organisms only containing Zn-independent form; 
Both, organisms containing both forms. The figure is taken from (88).
16

 
Figure 1. 
17

Figure 2.
18

Figure 3. 
19

Figure 4. 
20

Figure 5. 
21

Figure 6. 
22

 
 
REFERENCES 
1. Vogt, W. (1995) Oxidation of methionyl residues in proteins: tools, targets, and 
reversal, Free Radic Biol Med 18, 93-105. 
2. Brot, N., and Weissbach, H. (1983) Biochemistry and physiological role of 
methionine sulfoxide residues in proteins, Arch Biochem Biophys 223, 271-281. 
3. Shechter, Y. (1986) Selective oxidation and reduction of methionine residues in 
peptides and proteins by oxygen exchange between sulfoxide and sulfide, J Biol 
Chem 261, 66-70. 
4. Levine, R. L., Mosoni, L., Berlett, B. S., and Stadtman, E. R. (1996) Methionine 
residues as endogenous antioxidants in proteins, Proc Natl Acad Sci U S A 93, 15036-
15040. 
5. Levine, R. L., Berlett, B. S., Moskovitz, J., Mosoni, L., and Stadtman, E. R. (1999) 
Methionine residues may protect proteins from critical oxidative damage, Mech 
Ageing Dev 107, 323-332. 
6. Brot, N., Weissbach, L., Werth, J., and Weissbach, H. (1981) Enzymatic reduction of 
protein-bound methionine sulfoxide, Proc Natl Acad Sci U S A 78, 2155-2158. 
7. Ezraty, B., Aussel, L., and Barras, F. (2005) Methionine sulfoxide reductases in 
prokaryotes, Biochim Biophys Acta 1703, 221-229. 
8. Kryukov, G. V., Kumar, R. A., Koc, A., Sun, Z., and Gladyshev, V. N. (2002) 
Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide reductase, 
Proc Natl Acad Sci U S A 99, 4245-4250. 
9. Brot, N., and Weissbach, H. (2000) Peptide methionine sulfoxide reductase: 
biochemistry and physiological role, Biopolymers 55, 288-296. 
10. Ciorba, M. A., Heinemann, S. H., Weissbach, H., Brot, N., and Hoshi, T. (1997) 
Modulation of potassium channel function by methionine oxidation and reduction, 
Proc Natl Acad Sci U S A 94, 9932-9937. 
11. Ciorba, M. A., Heinemann, S. H., Weissbach, H., Brot, N., and Hoshi, T. (1999) 
Regulation of voltage-dependent K+ channels by methionine oxidation: effect of 
nitric oxide and vitamin C, FEBS Lett 442, 48-52. 
12. Yao, Y., Yin, D., Jas, G. S., Kuczer, K., Williams, T. D., Schoneich, C., and Squier, 
T. C. (1996) Oxidative modification of a carboxyl-terminal vicinal methionine in 
calmodulin by hydrogen peroxide inhibits calmodulin-dependent activation of the 
plasma membrane Ca-ATPase, Biochemistry 35, 2767-2787. 
13. Sun, H., Gao, J., Ferrington, D. A., Biesiada, H., Williams, T. D., and Squier, T. C. 
(1999) Repair of oxidized calmodulin by methionine sulfoxide reductase restores 
ability to activate the plasma membrane Ca-ATPase, Biochemistry 38, 105-112. 
14. Hansel, A., Heinemann, S. H., and Hoshi, T. (2005) Heterogeneity and function of 
mammalian MSRs: enzymes for repair, protection and regulation, Biochim Biophys 
Acta 1703, 239-247. 
15. Sharov, V. S., Ferrington, D. A., Squier, T. C., and Schoneich, C. (1999) 
Diastereoselective reduction of protein-bound methionine sulfoxide by methionine 
sulfoxide reductase, FEBS Lett 455, 247-250. 
16. Moskovitz, J., Poston, J. M., Berlett, B. S., Nosworthy, N. J., Szczepanowski, R., and 
Stadtman, E. R. (2000) Identification and characterization of a putative active site for 
peptide methionine sulfoxide reductase (MsrA) and its substrate stereospecificity, J 
Biol Chem 275, 14167-14172. 
23

17. Lee, B. C., Lee, Y. K., Lee, H. J., Stadtman, E. R., Lee, K. H., and Chung, N. (2005) 
Cloning and characterization of antioxidant enzyme methionine sulfoxide-S-reductase 
from Caenorhabditis elegans, Arch Biochem Biophys 434, 275-281. 
18. Boschi-Muller, S., Gand, A., and Branlant, G. (2008) The methionine sulfoxide 
reductases: Catalysis and substrate specificities, Arch Biochem Biophys 474, 266-273. 
19. Caldwell, P., Luk, D. C., Weissbach, H., and Brot, N. (1978) Oxidation of the 
methionine residues of Escherichia coli ribosomal protein L12 decreases the protein's 
biological activity, Proc Natl Acad Sci U S A 75, 5349-5352. 
20. Moskovitz, J., Weissbach, H., and Brot, N. (1996) Cloning the expression of a 
mammalian gene involved in the reduction of methionine sulfoxide residues in 
proteins, Proc Natl Acad Sci U S A 93, 2095-2099. 
21. Kuschel, L., Hansel, A., Schonherr, R., Weissbach, H., Brot, N., Hoshi, T., and 
Heinemann, S. H. (1999) Molecular cloning and functional expression of a human 
peptide methionine sulfoxide reductase (hMsrA), FEBS Lett 456, 17-21. 
22. Huang, W., Escribano, J., Sarfarazi, M., and Coca-Prados, M. (1999) Identification, 
expression and chromosome localization of a human gene encoding a novel protein 
with similarity to the pilB family of transcriptional factors (pilin) and to bacterial 
peptide methionine sulfoxide reductases, Gene 233, 233-240. 
23. Bar-Noy, S., and Moskovitz, J. (2002) Mouse methionine sulfoxide reductase B: 
effect of selenocysteine incorporation on its activity and expression of the seleno-
containing enzyme in bacterial and mammalian cells, Biochem Biophys Res Commun 
297, 956-961. 
24. Hansel, A., Jung, S., Hoshi, T., and Heinemann, S. H. (2003) A second human 
methionine sulfoxide reductase (hMSRB2) reducing methionine-R-sulfoxide displays 
a tissue expression pattern distinct from hMSRB1, Redox Rep 8, 384-388. 
25. Kim, H. Y., and Gladyshev, V. N. (2004) Methionine sulfoxide reduction in 
mammals: characterization of methionine-R-sulfoxide reductases, Mol Biol Cell 15, 
1055-1064. 
26. Kauffmann, B., Favier, F., Olry, A., Boschi-Muller, S., Carpentier, P., Branlant, G., 
and Aubry, A. (2002) Crystallization and preliminary X-ray diffraction studies of the 
peptide methionine sulfoxide reductase B domain of Neisseria meningitidis PILB, 
Acta Crystallogr D Biol Crystallogr 58, 1467-1469. 
27. Lowther, W. T., Weissbach, H., Etienne, F., Brot, N., and Matthews, B. W. (2002) 
The mirrored methionine sulfoxide reductases of Neisseria gonorrhoeae pilB, Nat 
Struct Biol 9, 348-352. 
28. Zhang, X. H., and Weissbach, H. (2008) Origin and evolution of the protein-repairing 
enzymes methionine sulphoxide reductases, Biol Rev Camb Philos Soc 83, 249-257. 
29. Lowther, W. T., Brot, N., Weissbach, H., and Matthews, B. W. (2000) Structure and 
mechanism of peptide methionine sulfoxide reductase, an "anti-oxidation" enzyme, 
Biochemistry 39, 13307-13312. 
30. Kumar, R. A., Koc, A., Cerny, R. L., and Gladyshev, V. N. (2002) Reaction 
mechanism, evolutionary analysis, and role of zinc in Drosophila methionine-R-
sulfoxide reductase, J Biol Chem 277, 37527-37535. 
31. Aachmann, F. L., Sal, L. S., Kim, H. Y., Marino, S. M., Gladyshev, V. N., and Dikiy, 
A. (2010) Insights into function, catalytic mechanism, and fold evolution of 
selenoprotein methionine sulfoxide reductase B1 through structural analysis, J Biol 
Chem 285, 33315-33323. 
32. Aachmann, F. L., Kwak, G. H., Del Conte, R., Kim, H. Y., Gladyshev, V. N., and 
Dikiy, A. (2011) Structural and biochemical analysis of mammalian methionine 
sulfoxide reductase B2, Proteins 79, 3123-3131. 
24

33. Singh, V. K., and Moskovitz, J. (2003) Multiple methionine sulfoxide reductase genes 
in Staphylococcus aureus: expression of activity and roles in tolerance of oxidative 
stress, Microbiology 149, 2739-2747. 
34. Olry, A., Boschi-Muller, S., Marraud, M., Sanglier-Cianferani, S., Van Dorsselear, 
A., and Branlant, G. (2002) Characterization of the methionine sulfoxide reductase 
activities of PILB, a probable virulence factor from Neisseria meningitidis, J Biol 
Chem 277, 12016-12022. 
35. Vougier, S., Mary, J., and Friguet, B. (2003) Subcellular localization of methionine 
sulphoxide reductase A (MsrA): evidence for mitochondrial and cytosolic isoforms in 
rat liver cells, Biochem J 373, 531-537. 
36. Lee, B. C., Dikiy, A., Kim, H. Y., and Gladyshev, V. N. (2009) Functions and 
evolution of selenoprotein methionine sulfoxide reductases, Biochim Biophys Acta 
1790, 1471-1477. 
37. Ohno, S. (1970) Evolution by gene duplication, Springer-Verlag, Berlin, New York,. 
38. Zhang, J. (2003) Evolution by gene duplication: an update, Trends in Ecology &amp; 
Evolution 18, 292-298. 
39. Zhang, J. (2012) Genetic Redundancies and Their Evolutionary Maintenance 
Evolutionary Systems Biology,  (Soyer, O. S., Ed.), pp 279-300, Springer New York. 
40. Go, Y. M., and Jones, D. P. (2008) Redox compartmentalization in eukaryotic cells, 
Biochim Biophys Acta 1780, 1273-1290. 
41. Neupert, W. (1997) Protein import into mitochondria, Annu Rev Biochem 66, 863-
917. 
42. Truscott, K. N., Pfanner, N., and Voos, W. (2001) Transport of proteins into 
mitochondria, Rev Physiol Biochem Pharmacol 143, 81-136. 
43. Kim, H. Y., and Gladyshev, V. N. (2006) Alternative first exon splicing regulates 
subcellular distribution of methionine sulfoxide reductases, BMC Mol Biol 7, 11. 
44. von Heijne, G. (1986) Towards a comparative anatomy of N-terminal topogenic 
protein sequences, J Mol Biol 189, 239-242. 
45. von Heijne, G. (1986) Mitochondrial targeting sequences may form amphiphilic 
helices, EMBO J 5, 1335-1342. 
46. Roise, D., and Schatz, G. (1988) Mitochondrial presequences, J Biol Chem 263, 4509-
4511. 
47. Lemire, B. D., Fankhauser, C., Baker, A., and Schatz, G. (1989) The mitochondrial 
targeting function of randomly generated peptide sequences correlates with predicted 
helical amphiphilicity, J Biol Chem 264, 20206-20215. 
48. von Heijne, G. (1990) Protein targeting signals, Curr Opin Cell Biol 2, 604-608. 
49. Kim, H. Y., and Gladyshev, V. N. (2004) Characterization of mouse endoplasmic 
reticulum methionine-R-sulfoxide reductase, Biochem Biophys Res Commun 320, 
1277-1283. 
50. Jung, S., Hansel, A., Kasperczyk, H., Hoshi, T., and Heinemann, S. H. (2002) 
Activity, tissue distribution and site-directed mutagenesis of a human peptide 
methionine sulfoxide reductase of type B: hCBS1, FEBS Lett 527, 91-94. 
51. Muttenthaler, M., and Alewood, P. F. (2008) Selenopeptide chemistry, J Pept Sci 14, 
1223-1239. 
52. Hondal, R. J., Nilsson, B. L., and Raines, R. T. (2001) Selenocysteine in native 
chemical ligation and expressed protein ligation, J Am Chem Soc 123, 5140-5141. 
53. Huber, R. E., and Criddle, R. S. (1967) Comparison of the chemical properties of 
selenocysteine and selenocystine with their sulfur analogs, Arch Biochem Biophys 
122, 164-173. 
25

54. Pearson, R. G., Sobel, H., and Songstad, J. (1968) Nucleophilic Reactivity Constants 
toward Methyl Iodide and Trans-[Pt(Py)2cl2], Journal of the American Chemical 
Society 90, 319-&. 
55. Kim, H. Y., and Gladyshev, V. N. (2005) Different catalytic mechanisms in 
mammalian selenocysteine- and cysteine-containing methionine-R-sulfoxide 
reductases, PLoS Biol 3, e375. 
56. Metanis, N., Keinan, E., and Dawson, P. E. (2006) Synthetic seleno-glutaredoxin 3 
analogues are highly reducing oxidoreductases with enhanced catalytic efficiency, J 
Am Chem Soc 128, 16684-16691. 
57. Bock, A., Forchhammer, K., Heider, J., and Baron, C. (1991) Selenoprotein synthesis: 
an expansion of the genetic code, Trends Biochem Sci 16, 463-467. 
58. Bell, I. M., Fisher, M. L., Wu, Z. P., and Hilvert, D. (1993) Kinetic studies on the 
peroxidase activity of selenosubtilisin, Biochemistry 32, 3754-3762. 
59. Stadtman, T. C. (1996) Selenocysteine, Annu Rev Biochem 65, 83-100. 
60. Hatfield, D. L., and Gladyshev, V. N. (2002) How selenium has altered our 
understanding of the genetic code, Mol Cell Biol 22, 3565-3576. 
61. Gromer, S., Johansson, L., Bauer, H., Arscott, L. D., Rauch, S., Ballou, D. P., 
Williams, C. H., Jr., Schirmer, R. H., and Arner, E. S. (2003) Active sites of 
thioredoxin reductases: why selenoproteins?, Proc Natl Acad Sci U S A 100, 12618-
12623. 
62. Yu, H. J., Liu, J. Q., Bock, A., Li, J., Luo, G. M., and Shen, J. C. (2005) Engineering 
glutathione transferase to a novel glutathione peroxidase mimic with high catalytic 
efficiency. Incorporation of selenocysteine into a glutathione-binding scaffold using 
an auxotrophic expression system, J Biol Chem 280, 11930-11935. 
63. Fomenko, D. E., Xing, W., Adair, B. M., Thomas, D. J., and Gladyshev, V. N. (2007) 
High-throughput identification of catalytic redox-active cysteine residues, Science 
315, 387-389. 
64. Novoselov, S. V., Rao, M., Onoshko, N. V., Zhi, H., Kryukov, G. V., Xiang, Y., 
Weeks, D. P., Hatfield, D. L., and Gladyshev, V. N. (2002) Selenoproteins and 
selenocysteine insertion system in the model plant cell system, Chlamydomonas 
reinhardtii, EMBO J 21, 3681-3693. 
65. Kim, H. Y., Fomenko, D. E., Yoon, Y. E., and Gladyshev, V. N. (2006) Catalytic 
advantages provided by selenocysteine in methionine-S-sulfoxide reductases, 
Biochemistry 45, 13697-13704. 
66. Kim, H. Y., and Gladyshev, V. N. (2007) Methionine sulfoxide reductases: 
selenoprotein forms and roles in antioxidant protein repair in mammals, Biochem J 
407, 321-329. 
67. Boschi-Muller, S., Azza, S., Sanglier-Cianferani, S., Talfournier, F., Van Dorsselear, 
A., and Branlant, G. (2000) A sulfenic acid enzyme intermediate is involved in the 
catalytic mechanism of peptide methionine sulfoxide reductase from Escherichia coli, 
J Biol Chem 275, 35908-35913. 
68. Boschi-Muller, S., Olry, A., Antoine, M., and Branlant, G. (2005) The enzymology 
and biochemistry of methionine sulfoxide reductases, Biochim Biophys Acta 1703, 
231-238. 
69. Olry, A., Boschi-Muller, S., and Branlant, G. (2004) Kinetic characterization of the 
catalytic mechanism of methionine sulfoxide reductase B from Neisseria meningitidis, 
Biochemistry 43, 11616-11622. 
70. Kim, H. Y., and Kim, J. R. (2008) Thioredoxin as a reducing agent for mammalian 
methionine sulfoxide reductases B lacking resolving cysteine, Biochem Biophys Res 
Commun 371, 490-494. 
26

71. Russel, M., and Model, P. (1986) The role of thioredoxin in filamentous phage 
assembly. Construction, isolation, and characterization of mutant thioredoxins, J Biol 
Chem 261, 14997-15005. 
72. Lin, T. Y. (1999) G33D mutant thioredoxin primarily affects the kinetics of reaction 
with thioredoxin reductase. Probing the structure of the mutant protein, Biochemistry 
38, 15508-15513. 
73. Dobrovolska, O., Rychkov, G., Shumilina, E., Nerinovski, K., Schmidt, A., Shabalin, 
K., Yakimov, A., and Dikiy, A. (2012) Structural insights into interaction between 
mammalian methionine sulfoxide reductase B1 and thioredoxin, J Biomed Biotechnol 
2012, 586539. 
74. Lee, T. H., and Kim, H. Y. (2008) An anaerobic bacterial MsrB model reveals 
catalytic mechanisms, advantages, and disadvantages provided by selenocysteine and 
cysteine in reduction of methionine-R-sulfoxide, Arch Biochem Biophys 478, 175-
180. 
75. Bertini, I., Sigel, A., and Sigel, H. (2001) Handbook on metalloproteins, Marcel 
Dekker, New York. 
76. Andreini, C., Bertini, I., Cavallaro, G., Holliday, G. L., and Thornton, J. M. (2008) 
Metal ions in biological catalysis: from enzyme databases to general principles, J Biol 
Inorg Chem 13, 1205-1218. 
77. Gladyshev, V. N., Jeang, K. T., and Stadtman, T. C. (1996) Selenocysteine, identified 
as the penultimate C-terminal residue in human T-cell thioredoxin reductase, 
corresponds to TGA in the human placental gene, Proc Natl Acad Sci U S A 93, 6146-
6151. 
78. Mulkidjanian, A. Y., and Galperin, M. Y. (2009) On the origin of life in the zinc 
world. 2. Validation of the hypothesis on the photosynthesizing zinc sulfide edifices 
as cradles of life on Earth, Biol Direct 4, 27. 
79. Auld, D. S. (2001) Zinc Sites in Metalloenzymes and Related Proteins., Handbook on 
metalloproteins ed., Marcel Dekker, New York. 
80. Auld, D. S. (2001) Zinc coordination sphere in biochemical zinc sites, Biometals 14, 
271-313. 
81. Vallee, B. L., and Auld, D. S. (1990) Zinc coordination, function, and structure of 
zinc enzymes and other proteins, Biochemistry 29, 5647-5659. 
82. Korndorfer, I. P., Fessner, W. D., and Matthews, B. W. (2000) The structure of 
rhamnose isomerase from Escherichia coli and its relation with xylose isomerase 
illustrates a change between inter and intra-subunit complementation during 
evolution, J Mol Biol 300, 917-933. 
83. Whitlow, M., Howard, A. J., Finzel, B. C., Poulos, T. L., Winborne, E., and Gilliland, 
G. L. (1991) A metal-mediated hydride shift mechanism for xylose isomerase based 
on the 1.6 A Streptomyces rubiginosus structures with xylitol and D-xylose, Proteins 
9, 153-173. 
84. Berry, M. B., and Phillips, G. N., Jr. (1998) Crystal structures of Bacillus 
stearothermophilus adenylate kinase with bound Ap5A, Mg2+ Ap5A, and Mn2+ 
Ap5A reveal an intermediate lid position and six coordinate octahedral geometry for 
bound Mg2+ and Mn2+, Proteins 32, 276-288. 
85. Perrier, V., Surewicz, W. K., Glaser, P., Martineau, L., Craescu, C. T., Fabian, H., 
Mantsch, H. H., Barzu, O., and Gilles, A. M. (1994) Zinc chelation and structural 
stability of adenylate kinase from Bacillus subtilis, Biochemistry 33, 9960-9967. 
86. Carfi, A., Pares, S., Duee, E., Galleni, M., Duez, C., Frere, J. M., and Dideberg, O. 
(1995) The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus 
reveals a new type of protein fold, EMBO J 14, 4914-4921. 
27

87. Fabiane, S. M., Sohi, M. K., Wan, T., Payne, D. J., Bateson, J. H., Mitchell, T., and 
Sutton, B. J. (1998) Crystal structure of the zinc-dependent beta-lactamase from 
Bacillus cereus at 1.9 A resolution: binuclear active site with features of a 
mononuclear enzyme, Biochemistry 37, 12404-12411. 
88. Zhang, Y., and Gladyshev, V. N. (2011) Comparative genomics of trace element 
dependence in biology, J Biol Chem 286, 23623-23629. 
89. Makarova, K. S., Ponomarev, V. A., and Koonin, E. V. (2001) Two C or not two C: 
recurrent disruption of Zn-ribbons, gene duplication, lineage-specific gene loss, and 
horizontal gene transfer in evolution of bacterial ribosomal proteins, Genome Biology 
2. 
90. Panina, E. M., Mironov, A. A., and Gelfand, M. S. (2003) Comparative genomics of 
bacterial zinc regulons: enhanced ion transport, pathogenesis, and rearrangement of 
ribosomal proteins, Proc Natl Acad Sci U S A 100, 9912-9917. 
91. Olry, A., Boschi-Muller, S., Yu, H., Burnel, D., and Branlant, G. (2005) Insights into 
the role of the metal binding site in methionine-R-sulfoxide reductases B, Protein Sci 
14, 2828-2837. 
92. Kim, Y. K., Shin, Y. J., Lee, W. H., Kim, H. Y., and Hwang, K. Y. (2009) Structural 
and kinetic analysis of an MsrA-MsrB fusion protein from Streptococcus 
pneumoniae, Mol Microbiol 72, 699-709. 
93. Ranaivoson, F. M., Neiers, F., Kauffmann, B., Boschi-Muller, S., Branlant, G., and 
Favier, F. (2009) Methionine sulfoxide reductase B displays a high level of flexibility, 
J Mol Biol 394, 83-93. 
94. Dobrovolska, O., Shumilina, E., Holen, H. W., and Dikiy, A. (to be published) 
Structural and biochemical insights into mammalian cobalt-substituted methionine 
sulfoxide reductase B1. 
95. Lippard, S. J., and Berg, J. M. (1994) Principles of bioinorganic chemistry, University 
Science Books, Mill Valley, Calif. 
96. Bertini, I., Sigel, A., and Sigel, H. (2001) Handbook on Metalloproteins, Marcel 
Dekker. 
97. Gerdts, C. J., Elliott, M., Lovell, S., Mixon, M. B., Napuli, A. J., Staker, B. L., 
Nollert, P., and Stewart, L. (2008) The plug-based nanovolume Microcapillary 
Protein Crystallization System (MPCS), Acta Crystallographica Section D 64, 1116-
1122. 
98. Lange, O. F., Rossi, P., Sgourakis, N. G., Song, Y., Lee, H. W., Aramini, J. M., 
Ertekin, A., Xiao, R., Acton, T. B., Montelione, G. T., and Baker, D. (2012) 
Determination of solution structures of proteins up to 40 kDa using CS-Rosetta with 
sparse NMR data from deuterated samples, Proc Natl Acad Sci U S A 109, 10873-
10878. 
 
 
 
 
 
Paper III
Subject: PLOS ONE Decision: Accept [PONE-D-12-31959R1]
Date: Thu, 22 Nov 2012 06:26:43 -0500 
From: PLOS ONE <plosone@plos.org>
To: Alexander Dikiy <alex.dikiy@biotech.ntnu.no>
PONE-D-12-31959R1 
Structural analysis of glutaredoxin domain of Mus musculus thioredoxin 
glutathione reductase 
PLOS ONE 
 
Dear Prof. Dikiy, 
 
I am pleased to inform you that your manuscript has been deemed suitable 
for publication in PLOS ONE.  
 
Your manuscript will now be passed on to our Production staff, who will 
check your files for correct formatting and completeness. After this review, 
they may return your manuscript to you so that you can make necessary 
alterations and upload a final version. 
 
Before uploading, you should check the PDF of your manuscript very 
closely. There is no author proofing. You should therefore consider the 
corrected files you upload now as equivalent to a production proof. The text 
you supply at this point will be faithfully represented in your published 
manuscript exactly as you supply it. This is your last opportunity to correct 
any errors that are present in your manuscript files.  
 
 
With kind regards, 
Michael Massiah 
Academic Editor 
PLOS ONE
Structural analysis of glutaredoxin domain of Mus musculus thioredoxin 
glutathione reductase 
Olena Dobrovolska1, Elena Shumilina1, Vadim N. Gladyshev2 and Alexander Dikiy1,* 
1Department of Biotechnology, Norwegian University of Science and Technology, N-7491 
Trondheim, Norway 
2Genetics Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical 
School, Boston, MA 02115, USA 
 
Keywords: 
Thioredoxin reductase, Glutaredoxin, Protein structure, Bioinformatics, Alignment, Protein function 
 
 
 
 
 
 
 
Abbreviations: TR, thioredoxin reductase; GR, glutathione reductase; Grx, glutaredoxin; GSH, 
reduced glutathione; GSSG, oxidized glutathione; GPx, glutathione peroxidase; TGR, thioredoxin 
glutathione reductase; NADPH, nicotinamide adenine dinucleotide phosphate; NMR, nuclear 
magnetic resonance; NOE, nuclear Overhauser effect; Sm, Schistosoma mansoni; SmTGR, 
thioredoxin glutathione reductase from Schistosoma mansoni. 
*Corresponding author: Tel.:+4773597863, Fax: +4773591283; E-mail: alex.dikiy@biotech.ntnu.no 
 
Abstract
Thioredoxin glutathione reductase (TGR) is a member of the mammalian thioredoxin 
reductase family that has a monothiol glutaredoxin (Grx) domain attached to the thioredoxin 
reductase module. Here, we report a structure of the Grx domain of mouse TGR, determined 
through high resolution NMR spectroscopy to the final backbone RMSD value of 0.48±0.10 
Å. The structure represents a sandwich-like molecule composed of a four stranded ȕ-sheet 
flanked by five Į–helixes, with the CxxS active motif located on the catalytic loop. We 
structurally characterized the glutathione-binding site in the protein and describe sequence 
and structural relationships of the domain with glutaredoxins. The structure illuminates a key 
functional center that evolved in mammalian TGRs to act in thiol-disulfide reactions. Our 
study allows us to hypothesize that Cys105 might be functionally relevant for TGR catalysis. 
In addition, the data suggest that the N-terminus of Grx acts as a possible regulatory signal 
also protecting the protein active site from unwanted interactions in cellular cytosol. 



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Introduction
 Thioredoxin (Trx) and glutaredoxin (Grx) systems are two major thiol pathways that 
control cellular redox homeostasis [1]. The Trx system is composed of thioredoxin reductase 
(TR), thioredoxin (Trx) and Trx peroxidase, whereas the Grx system consists of glutathione 
reductase (GR), glutathione (Ȗ-Glu-Cys-Gly tripeptide; GSH), glutaredoxin (Grx) and 
glutathione peroxidase (GPx). In these systems, electron flow is directed from NADPH 
through GR and TR towards their respective protein substrates. GR and TR belong to the 
pyridine nucleotide-disulfide oxidoreductase family. They are homodimers and contain a 
tightly bound FAD molecule in each subunit [1]. Mammalian TR and GR were found to be 
structurally and functionally similar, although TR has an additional C-terminal 
selenocysteine-containing active site, which serves as a substrate for the N-terminal active site 
[2,3,4,5,6,7]. 
 Three TRs genes have been identified in humans, including TXNRD1 (cytosolic TR, 
TR1), TXNRD2 (mitochondrial TR, TR3) and TXNRD3 (thioredoxin glutathione reductase, 
TGR) [8,9,10,11,12,13]. TGR is unusual among TRs in that it has an additional N-terminal 
Grx domain, which is fused to a canonical TR module [13,14,15,16]. The amino acid 
sequence of the TR module of TGR is more closely related to TR1 than to TR3 [13] and its 
Grx domain has a monothiol CPHS catalytic motif [13,14,15,17]. The active site motif of the 
Grx domain of TGR can receive electrons from either the TR module or from GSH, and the 
protein was proposed to function predominantly in disulfide bond formation and 
isomerization in sperm proteins during spermatogenesis [14]. Mammalian TGR exhibits broad 
substrate specificity and can reduce various components of both Trx and Grx systems [16]. In 
particular, it was demonstrated that TGR can catalyze reactions associated with Grx 
(deglutathionylation), GR (NADPH-dependent reduction of GSSG) and TR (NADPH-
dependent reduction of Trx) activities. It was argued that Grx and GR activities of TGR are 
mediated by its Grx domain [16].  
 Structural characterization of proteins is an essential step for establishment of their 
functional peculiarities. Structures of platyhelminth TGR (pdb code 2V6O) and the Grx 
domain of human TGR (pdb code 3H8Q) have been recently determined. We previously 
reported NMR resonance assignments of full-length and shortened (lacking 22 N-terminal 
amino acids) forms of the Grx domain of Mus musculus TGR [18]. In the present work, we 
report solution structure of this Grx domain using high-resolution NMR spectroscopy. This 
Trx-fold structure validates the model of the Grx domain [19] and is consistent with the 
structures of other Grx. We further used the structure to carry out comparative sequence, 
structure and charge distribution analyses of Grx and Grx domains in order to explain 
structural and functional peculiarities of the TGR’s Grx domain.  
 
Materials and methods 
Reduced glutathione (GSH) was purchased from Acros Organics, and oxidized 
glutathione (GSSG) from Sigma Aldrich. Both compounds were dissolved in a buffer 
containing 10 mM sodium phosphate, 10 mM NaCl, pH 7.5.
 Sample preparation 
 Protein expression and purification of a uniformly isotope labeled (15N/13C) His-
tagged version of the full-length and shortened forms of the Grx domain of mouse TGR 
(hereafter Grx and sGrx, respectively) was carried out as described previously [18]. NMR 
samples of reduced 1 mM Grx or sGrx in 10 mM sodium phosphate buffer, 10 mM NaCl, 10 
mM ȕ-mercaptoethanol, in 95% H2O/5% D2O and 100% D2O, pH 7.5, were analyzed by 
NMR. 
 NMR spectroscopy 
 NMR spectra were recorded at 298 K on a Bruker Avance 600 MHz spectrometer 
equipped with a 5-mm z-gradient TXI (H/C/N) cryoprobe. Three-dimensional 13C- and 15N-
edited 1H Nuclear Overhauser Effect Spectroscopy (NOESY) spectra were recorded in D2O 
and H2O, respectively. NMR data were processed using Bruker XWinNMR, version 3.5. 
NMR spectral analysis was performed using CARA version 1.8.4.2.  
 Structure calculation 
 NOE cross-peaks were identified, assigned and integrated in the aforementioned 
NOESY spectra using the CARA program. The CALIBA subroutine in CYANA 2.1 was used 
to convert cross peak intensities to distance constraints. Dihedral angle constraints were 
derived from secondary chemical shifts using the TALOS program [20]. Based on the input, 
the structure was calculated using the torsion angle dynamics program CYANA2.1 [21]. 
Twenty  conformers with the lowest final CYANA target function values were further energy 
minimized in vacuum using AMBER force field with the aid of AMBER 9 program [22]. The 
mean structure was generated using MOLMOL 2k.2.0 [23] and further energy minimized in 
AMBER. 
 
 Structure analysis 
Quality of structures was analyzed using MOLMOL and PROCHECK - NMR [24]. 
The relevant figures and electrostatic potentials were prepared using MOLMOL version 
2k.2.0. 
 NMR experiments 
 In order to characterize the glutathione-binding site of Grx NMR 15N-1H HSQC 
titration experiments were performed. A 1 mM sample of 15N-labeled Grx in buffer,  
containing 10 mM sodium phosphate, 10 mM NaCl, pH 7.5, was titrated with unlabeled GSH 
and GSSG at room temperature in the following proportions: 1:1/3; 1:1/2; 1:2/3; 1:1; 1:2; 
1:10, either in the absence or presence of 10 mM ȕ-mercaptoethanol. In the membrane 
environmental modeling experiment, 5% w/v SDS was added to the solution of 15N-labeled 
Grx and the 15N-1H HSQC spectra of the mixture were recorded at 30°C and 42°C. For water 
exchange experiments, samples of 15N-labeled Grx or sGrx in the NMR buffer were 
lyophilized and further dissolved in D2O. A course of subsequent 15N-1H HSQC spectra for 
each protein was recorded every 30 min. 
 Bioinformatics analysis 
Protein multiple sequence alignments were performed with ClustalW [25]. Sequence 
similarity analysis was performed by the SIAS server 
(http://imed.med.ucm.es/Tools/sias.html). Structural superimposition was carried out using 
SuperPose [26]. An analysis of the N-terminal region (residues 1-22) was performed using 
iPSORT [27] and MITOPROT [28]. 

Results and Discussion 
 Structure description. Solution structure of the Grx domain of mouse TGR was 
calculated based on the NOE-derived geometrical constraints and dihedral angles obtained 
from TALOS. The geometrical constraints used in the calculations are summarized in Table 1. 
In total, 894 NOE-based upper distance limits and 182 ȥ and ĳ torsion angle restraints were 
used to derive the Grx structure. The resulting Grx family was further energy-minimized. The 
geometrical constraints and coordinate files of the minimized Grx family were deposited in 
the PDB under the code 2lv3. Figure 1 shows a superimposition of the final 20 minimized 
conformers with the lowest target function, together with a ribbon representation of the 
minimized conformer closest to the mean structure showing the secondary structure elements, 
active site cysteine C48, and C-terminal C105 (further discussed). The calculated structure is 
of high quality and fully corresponds to the experimentally determined constraints. 
 The N-terminal region of Grx (first 22 amino acids) was excluded from the structure 
calculation as most of the corresponding HSQC and NOE signals were not detected [18]; 
hence, the structure of Grx starts with Ala 23. Analysis of the structure shows that the Grx 
domain is a compact Trx-like spherical molecule with a central core of four-stranded ȕ-sheets 
flanked on either side by five Į-helices arranged in the order Į1-ȕ1-Į2-ȕ2-Į3-ȕ3-ȕ4-Į4-Į5 
(Figure 1). The N-terminal region begins with an Į1 (residues Arg 24 - Glu 36), followed by 
ȕ1 consisting of residues Val 40 to Ser 44. The active site Cys 48 - Ser 51 (-CPHS- motif) is 
situated on the unstructured loop between ȕ1 and Į2 (residues Arg 53 – Ser 59). The strand ȕ2 
comprises residues Asn 66 to Glu 69; following a loop, Į3 consists of residues Gly 76 to Ser 
87, followed by ȕ3 (Asn 94 – Val 97) and ȕ4 (Val 100 – Gly 103). The C-terminal region 
includes Į4 (residues Arg 107 – Asn 114) and Į5 (residues Leu 116 – Leu 120), connected 
through a hinge section. Strands ȕ1 and ȕ2 are parallel, and strand ȕ3 is antiparallel with ȕ1 and 
ȕ4. Helices Į1 and Į3 pack on one side of the ȕ-sheet, whereas Į2, Į4 and Į5 are on the other. 
Packing of the sandwich-like architecture is mainly maintained by hydrophobic interactions 
between the sheet and helices. The determined Grx structure shares significant structural 
similarity with the modelled Grx domain of mouse TGR [19].
 N-terminal region. As mentioned above, the N-terminal region of Grx was not 
detectable in HSQC and NOE spectra. The absence of the corresponding cross-peaks could be 
attributed to the higher mobility of this protein region. A decrease in temperature may slow 
down protein mobility and thus allow detecting the missing cross-peaks. Nevertheless, the 
15N-1H HSQC spectra of Grx recorded at a lower temperature (8°C) did not show additional 
signals in the spectra (data not shown). Further analysis of the first 22 amino acids of Grx 
using iPSORT suggested the presence of a candidate mitochondrial targeting peptide. Indeed, 
the N-terminal sequence is rich in positively charged and hydrophobic residues that may 
constitute the targeting helix [29]. Analysis of the N-terminus performed by MITOPROT 
predicted the cleavage site after the first 19 residues (MSSPPGRRARLASPGTSRP). 
However, analysis of cellular distribution of TGR suggested that the enzyme occurs in the 
cytosol of spermatids at the time of mitochondrial sheath formation [14]. In these spermatids, 
TGR is accumulated near the site of mitochondrial sheath assembly. It was shown that 
mammalian sperm is stabilized by disulfide bond (S-S) bridges cross-linking thiol-rich 
proteins present in the membranes of sperm mitochondria [30]. Thus, TGR, which combines 
the elements of Grx and Trx systems, might be involved in disulfide bond formation during 
spermatogenesis. The N-terminus can also act as a regulatory sequence. Showing little 
structural organization in solution, mitochondrial targeting sequences are predicted to form 
amphipathic Į-helixes in the membrane or membrane-like environment. The amphipathic 
nature of these structures is thought to be important for their specific recognition by the 
protein import machinery [31]. A membrane-like media are prepared by self-association of 
surfactants in aqueous solutions, which are divided into two large groups: detergents (form 
micelles) and lipids (form bilayers) [32]. For preparation of micelles, which are widely used 
in NMR structural studies, negatively charged SDS detergent is often used [33]. In NMR 
spectroscopy, the formation of the protein’s secondary structure results in the appearance of a 
set of well-dispersed HSQC cross-peaks. To further examine the N-terminal part of Grx, we 
recorded 15N-1H HSQC spectra of the SDS-treated Grx domain at 30°C and 42°C [34]. The 
obtained 15N-1H HSQC pattern was shifted towards the lower field of both dimensions; 
however, it did not change dramatically, and, as expected, contained additional well-dispersed 
cross-peaks, as shown in Figure 2. The number of new cross-peaks corresponded to (but did 
not exceed that of) the number of amino acids constituting the N-terminal segment, therefore, 
confirming that the positively charged N-terminus becomes structured in the negatively 
charged environment. 
 Although the 1H-15NHSQC patterns of Grx and sGrx resemble each other, indicating 
overall structural correspondence of the two protein forms, several differences between them 
were observed. First, the full-length protein had a higher stability than the shortened form. 
Second, the signals in 15N-1H HSQC, corresponding to residues C105 and D106, were not 
found in Grx, while they were present and assigned in sGrx [18]. Weak HSQC signals and 
any NOESY patterns were also found for residues D74 and A77 in the corresponding spectra 
of Grx [18]. These findings correlating with the presence/absence of the N-terminus further 
highlight structural differences between the two protein forms (see the following paragraphs).  
Electrostatic potential. Figure 3 shows electrostatic potential calculated for the 
obtained structure of Grx. It is apparent from the analysis of this figure, that the missing NOE 
signals of D74, A77, C105, D106 (see above) amino acids belong to the negatively charged 
region closest to the N-terminus. As the N-terminal region of Grx is composed of positively 
charged (R7, R8, R10, R18) and polar (S2, S3, S13, T16, S17, S20, S21) amino acids, their 
involvement in electrostatic interaction with negatively charged protein surface can be 
suggested. The broadening of the NMR signals corresponding to D74, A77, C105, D106 due 
to this interaction may be a reason that the mentioned amino acid signals in the NMR spectra 
of the full length form of Grx where not detected. Indeed, the resonances belonging to D74, 
A77, C105, D106, not observed in Grx protein, were firmly detected in sGrx lacking the 
mentioned electrostatic interaction.  Interestingly, the active site motif of Grx (C48, P49, H50, 
S51), as monitored by our structural studies, resides on the neighbouring loop near residues 
C105 and D106. Thus, the N-terminal region, positioned in proximity to the active site, could 
shield it from the solvent and, therefore, protect from unwanted reactions stabilizing the full-
length protein. 
D2O exchange experiments. To further comparatively characterize both Grx and sGrx 
proteins, we carried out water exchange experiments monitoring behaviour of 15N-1H HSQC 
spectra  in D2O for both full-length and shortened forms of the 15N-labeled Grx domain of 
TGR. Interestingly, during the first 30 minutes in D2O, Grx exchanged ten residues more with 
respect to sGrx (D33, G37, N38, V40, S59, V63, D71, Q72, E85, T108). However, after 3 
hours of incubation in D2O, both Grx and sGrx reveal an identical pattern of exchanged/not 
exchanged residues. Therefore, our experiments show that while the final rate of water 
exchange is the same both for Grx and sGrx, the short term dynamics of the water exchange is 
different for these proteins. The observed differences mostly regard residues belonging to the 
negative patch involved in the suggested interaction with the positively charged N-terminus 
(see above). The fact that these residues exchanged within the first 30 min in Grx, while in 
sGrx they exchanged only 3 hours later indicates that the N-terminus in some way promotes 
faster rates of water diffusion into Grx protein.  
Comparative sequence analysis of Grx. Grx occur in the majority of organisms in the 
three domains of life. Structures of many of these proteins were determined either by NMR or 
X-ray crystallography. Two main groups of Grx can be distinguished based on phylogeny, 
active site motifs, and domain structure: (i) ‘classical’ dithiol Grx containing the active site 
consensus sequence Cys-X-X-Cys (i.e., two Cys separated by two other amino acids); and (ii) 
monothiol Grx with a Cys-X-X-Ser active site consensus sequence. The latter Grx utilize only 
the N-terminal active site Cys in their catalytic mechanism, which is used together with two 
glutathione molecules, while dithiol Grx can use either one or both Cys in the active site. Both 
types of disulfides formed during Grx catalysis are reduced in vitro by GSH or TRs [35].  
 We analyzed an alignment of the Grx domain of mouse TGR with both Grx and Grx 
domains of TGR from various organisms, which contain mono- or dithiol active sites (Figure 
4). The active site residues (highlighted with a red rectangle), and residues involved in the 
interaction with GSH (marked with black rectangles) are conserved in mono- and dithiol Grx, 
including the Grx of mouse TGR [36].   
 Since interaction of the Grx domain with glutathione is assisted by electrostatic 
interactions, we next analysed the distribution of charged amino acids. As shown in the figure 
4, the active site of Grx is surrounded by positively charged amino acids (marked in blue). 
Interestingly, only in E. coli Grx3 and the Grx domain of Xenopus laevis TGR, negative 
residues are found in the vicinity of the active site (Fig.5, marked in red). It was suggested 
that these negative residues influence the redox potential of these proteins [37].  In addition, 
the C-terminal segment of the Grx domain of TGR from human, mouse, Danio rerio, Xenopus
laevis and Grx3 from E. coli harbor an additional Cys residue. Our structural data indicate that 
the distance between the active site cysteine (Cys 48) and C-terminal Cys105 (Figure 1, right 
panel) is 10-15 Å. Although the distance might be too large for the formation of an intra-
molecular disulfide bridge, according to our data there is no steric hindrance between these 
two cysteines located on unstructured loops. It can be hypothesised that the formation of an 
intra-molecular disulfide bridge between the two cysteine residues (e.g., as observed in 
mammalian MsrB1 protein [38,39]) may have functional and, perhaps, even catalytic 
relevance. 
Structural comparison with other Grx. Our analysis, as well as other structural studies 
of a set of GSH-dependent Grx [26] revealed common elements present in their binding sites: 
i) a CXXC/S active site motif; ii) a Tyr or a Phe in close proximity to the catalytic Cys; iii) a 
TVP motif with Pro in the cis conformation; iv) a GG kink in proximity to the active site; and 
v) conservation of charged residues at both edges of the substrate binding groove (GSH 
binding pocket). The structure of the Grx domain of mouse TGR was generally similar to 
other Grx structures, but varied in secondary structure elements attached to a common Grx 
core. For example, an N-terminal Į-helix (Į1 in our structure) was present in many Grx 
including human TGR (PDB code 3H8Q), human Grx2 (PDB code 2FLS), Grx of SmTGR 
(PDB code 2V6O), monothiol E. coli Grx4 (PDB code 1YKA), and poplar Grx C1 (PDB code 
2E7P), but not in the dithiol E. coli Grx3 (PDB code 1FOV). A lack of C- and/or N-terminal 
Į-helices together with the length of the loop preceding the active site motif, was suggested to 
play a key role in constraining the degree of conformational adaptability for substrate binding 
displayed by Grx [40]. Minor structural differences were also observed between the Grx 
domain of mouse TGR and the Grx domain of SmTGR: the latter was characterized by a 
shorter C-terminal Į-helix [41].  
Recent studies [42] demonstrated that SmTGR may function via two catalytic 
mechanisms: monothiol and dithiol. In the monothiol mechanism, when the GSH 
concentration is high, glutathionylated catalytic Cys (Cys28) of Grx gets resolved by GSH. At 
low GSH concentrations, a second, dithiol mechanism applies, wherein the C-terminal Cys 
(Cys31) in the CXXC motif acts as a resolving group, breaking the disulfide bond between 
Cys28 and GSH, forming an internal Cys28-Cys31 disulfide and releasing GSH. An oxidized 
Grx can be further reduced by the redox-active Cys/Sec–Cys pair of the TR domain [43]. The 
same study analyzed the deglutathionylation activities of a SmTGR variant, in which Cys31 
was replaced with Ser (making it analogous to mouse TGR), which exhibited 22% of wild 
type SmTGR activity. This study suggested that the role of the second Cys in the monothiol 
mechanism is to stabilize the thiolate anion of the N-terminal Cys through a hydrogen bond, 
thus facilitating its nucleophilic attack on GSSG.  
Grx titration with GSH/GSSG. Figure 5 illustrates fragments of the 15N-1H HSQC 
titration of the Grx domain with reduced (Figure 5A) and oxidized (Figure 5B) glutathione. 
Upon interaction with these two molecules the chemical environment of the nuclei involved in 
the interaction changes, which results in perturbation of the corresponding NMR signal: i.e., 
chemical shift change or signal broadening occurs. By performing NMR titration of 15N-
labeled Grx with its unlabelled partners, GSH and GSSG, we monitored their interaction and 
mapped the Grx residues involved in binding with the respective partners.  
Upon titration of Grx with either GSH or GSSG, nearly 90% of the signals remained 
unaltered; however, some of the signals appear changed (mostly broadened). The titration 
experiments of the Grx domain titration with GSH revealed signal broadening that 
corresponded to the following amino acids: S44, K45, C48, P49, H50, S51, T52, R53, V54, 
E81, T91, V92, P93, N94, G103, G104, R107. Grx titration with GSSG showed changes for 
the following residues: N38, K45, C48, P49, H50, S51, T52, R53, V54, E81, T91, V92, P93, 
N94, G103, G104, and R107 (Figure 5C). Interestingly, amino acids observed in the two 
experiments almost coincided. These experimental data not only point to the glutathione 
binding site in the Grx domain of TGR, but also suggest that the binding sites for reduced and 
oxidized glutathione largely overlap.  
Conclusions
This study describes the NMR solution structure of the monothiol Grx domain of 
mouse TGR. As expected, the protein possesses a Trx fold and consists of a four-stranded ȕ-
sheet flanked by five Į-helices. The active site motif containing the catalytic redox-active Cys 
is located on the protruding loop connecting strand ȕ1 and Į2.  
Analysis of the N-terminal segment of Grx, which was not included in the structure 
determination, showed that it has features of a targeting sequence or a regulatory region. It 
was found, by analyzing 15N-1H HSQC spectra, that this segment becomes structured when 
protein is treated with a detergent, thereby mimicking membrane-like environment. Based on 
the analysis of surface charge distribution of the protein, we suggest that the N-terminus 
resides near the active site, shielding it from redox interactions.   
Sequence alignment of the domains with other Grx and Grx domains revealed a 
characteristic GSH-binding site, which was further characterized with the help of NMR. The 
data suggest a significant overlap between the GSH and GSSG binding sites. Further analysis 
of mammalian TGR function would require structural information of the entire enzyme.  
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Figure Legends
 Figure 1. Solution structure of the reduced Grx domain of mouse TGR. Left: 
overview of backbone superimposition of 20 conformers with the lowest target function. 
Right: overview of the ribbon representation of the minimized conformer closest to the mean 
structure. The figure also shows the active site cysteine (C48) and C-terminal C105. 
 Figure 2. A fragment of 15N-1H HSQC spectra of the reduced Grx domain of 
mouse TGR. Green shows Grx HSQC spectrum at 30°C, light blue shows Grx HSQC 
spectrum in the presence of SDS at 30°C, and black corresponds to Grx HSQC spectrum in 
the presence of SDS at 42°C. For more details see the text. 
 Figure 3. Surface charge distribution of the reduced Grx domain of mouse TGR.  
 Figure 4. Amino acid sequence alignment of the Grx domain of mouse TGR with 
mono- and dithiol Grx from various organisms. The active site residues of Grx are 
highlighted with a red rectangle, and the residues involved in the interaction with glutathione 
are within black rectangles. Positive and negative charged amino acids are marked with blue 
and red colour, respectively. Cysteines residues are marked in green. Sequences abbreviation: 
HS, Homo sapiens; SM, Schistosoma mansoni; XL, Xenopus laevis; MM, Mus musculus; DR, 
Danio rerio; EC, Escherichia coli. 
 Figure 5. Fragments of 15N-1H HSQC spectra of 15N-labeled reduced Grx domain 
of mouse TGR titrated with unlabelled GSH and GSSG (panels A and B, respectively). 
Green corresponds to free Grx and magenta to Grx incubated with GSH/GSSG. Only the 
residues for which alteration of NMR parameters upon titration was observed are marked. 
Panel C: qualitative representation of the data. Solid and dashed horizontal lines below the 
Grx amino acid sequence highlight the residues interacting with GSH and GSSG, 
respectively.The N-term of Grx is marked in blue. For more details see the text. 
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 Table 1. Structural statistics and geometrical constraints derived from NMR for 
the reduced form of the Grx domain of mouse TGR. 
Restraints used in structure calculation Number 
 
Total number of NOE distance restraints 
Intrarresidual 
Medium range 
Long range 
Torsion angle constraints  
 
894 
161 
473 
260 
182 
Structure statistics, 20 conformers 
CYANA target function value (Å2) 
Maximal distance constraint violation (Å2) 
Maximal torsion angle constraint violation (Å2) 
AMBER energies in vacuum (kcal/mol) 
 
6.48 ± 0.27 
0.44 ± 0.18 
22.79 ± 0.9 
-2.95E +3 
PROCHECK – NMR Ramachandran statistics 
Residues in favourable regions (%) 
Residues in additional allowed regions (%) 
Residues in generously allowed regions (%) 
Residues in disallowed regions (%) 
 
87,8 
6,7 
3,3 
2,2 
Root mean square deviation to average coordinates (Å) 
N, CĮ, C’ (23 -124) 
Heavy atoms (23 -124) 
 
0,48 ± 0,10 
0.99 ± 0,11 
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Grx-TGR MM areelrrrlrdliegnrvmifsk sycphs trvkelfsslg---vvynileldqvddgasvq evlteisn-qk
Grx-TGR HS areelrrhlvgliersrvvifsk sycphs trvkelfsslg---vecnvleldqvddgarvq evlseitn-qk
TGR DR greqirskikelidssavvvfsk sfcpfc vkvkdlfkeln---vkyntieldlmedgtnyq dllhemtg-qk
TGR XL grdllqarvkelidsnrvmvfsk sfcpyc drvkdlfsslg---aeyhsleldecddgsdiq ealqeltg-qk
Grx1 EC ---------------mqtvifgr pgcpyc vrakdlaeklsnerddfqyqyvdiraegitke dlqqkagkpve
Grx3 EC --------------manveiytk etcpyc hrakallsskg-----vsfqelpidgnaakre emikrsgrt--
Grx2 HS latapvnqiqetisdncvvifsk tscsyc tmakklfhdmn---vnykvveldlleygnqfq dalykmtg-er
TGR SM padgtsqwlrktvdsaavilfsk ttcpyc kkvkdvlaeak---ikhatieldqlsngsaiq kclasfski-e
Grx-TGR MM tvpnifvnkvhv ggcdrtfqahqngllqkllqdd
Grx-TGR HS tvpnifvnkvhv ggcdqtfqayqsgllqkllqed
TGR DR tvpnvfinkkhi ggcdntmkahkdgvlqkllgeg
TGR XL tvpnvfvnkthv ggcdktlqahkdgslakllddn
Grx1 EC tvpqifvdqqhi ggytdfaawaken-lda
Grx3 EC tvpqifidaqhi ggcddlyaldarggldpllk
Grx2 HS tvprifvngtfi ggatdthrlhkegkllplvhqc
TGR SM tvpqmfvrgkfi gdsqtvlkyysndelagivnes 
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